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ABSTRACT
Lipid peroxidation is the process by which lipids in the cell membrane
undergo free radical-initiated oxidation. The resulting cell damage has been
implicated in the onset of many diseases, including as cancer, aging, and
stroke. Lipid oxidation has been studied in a variety of membrane models,
including homogeneous solution, micelles, liposomes, and microsomes. The
kinetics for free radical reactions proven to occur during lipid oxidation in
homogeneous solution have been thoroughly elucidated. These kinetics
were also shown to apply to oxidation in micelles. This dissertation
presents evidence that the kinetics o f more biologically realistic membrane
models such as liposomes may be quite different. Antioxidants such as atocopherol (a-T) have been shown to inhibit lipid oxidation. Work presented
here suggests that the efficiency with which antioxidants inhibit oxidation is
dependent on the structure of the membrane model. It was observed that the
antioxidant efficiency of a-T decreases dramatically from homogeneous to
heterogeneous systems of lipid, including micelles, liposomes, and microsomes.
This could be due to a decrease in fluidity in the membrane model, limiting the
diffusion of a-T. A less mobile antioxidant may have fewer opportunities for
encountering and trapping free radicals. Addition of free fatty acids (FFA) to the
membrane model to mimic damaged tissue enhanced a-T s efficiency.
Differential Scanning Calorimetry data show there is an increase in fluidity when
FFA are present, indicating a-T should then diffuse more readily through the

xi
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membrane. This work thus demonstrates that while a-T appears effective in
homogeneous solution, micelles, and liposome models of damaged membranes,
its antioxidant efficiency is much smaiier in bioiogicaiiy reievant modeis for
normal tissues. Furthermore, the concentration of a-T required to inhibit
oxidation in liposomes is greater than that which exists in tissues in vivo. Finally,
the antioxidant effectiveness of several synthetic antioxidant drugs called
21-aminosteroids was compared with that of a-T. It is shown here that a-T is
much more effective than any of the 21 -aminosteroids. In addition, the 21 aminosteroids were shown to be much less effective below pH 7.0. This may be
important in damaged tissue, where the pH reportedly falls to as low as 5.9.

xii
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CHAPTER 1: INTRODUCTION

1
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2
1.1. Autoxidation and its biological initiation
It is generally well understood that oxygen is critical to life. Naturally
occurring oxygen exists as a diradical, shown below.1When this oxygen species
••
•

•

undergoes one-electron reduction, for example by NADPH to form NADP+, the
result is an oxygen species with a highly reactive unpaired electron called a free
radical.2This oxygen species, 0 2'~, is termed superoxide. Superoxide is
involved in and is essential to many important biological processes, including
the detoxifying reaction of cytochrome P450, phagocytosis, and prostaglandin
biosynthesis. M
The reduction of hydrogen peroxide can lead to the formation of hydroxyl
radical (’O H).6 Low levels of hydroxyl radical normally exist in the body.7 This
highly reactive free radical can attack and oxidize almost any component of
human cells, eventually resulting in cell death.8,9 Fortunately, nature provides
the body with its own defense - antioxidants - to protect against this oxidative
damage. Typical antioxidants react with free radicals to produce non-radical
products and prevent further oxidative damage to tissues.10 Natural
antioxidants, discussed in length in a later section, include a-tocopherol,
p-carotene, ascorbic acid, and enzymes such as superoxide dismutase and
catalase, to name a fe w .11
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3
As long as there is a balance in the body between the formation of free
radicals and antioxidation, tissues remain healthy. When tissues become
stressed by any one of a number of factors including ionizing radiation,
traumatic injury, or inflammation, the production of free radicals exceeds
antioxidation.12 When this occurs, wide-scale lipid peroxidation results in tissue
damage.
Lipid peroxidation is a free-radical process in which lipids in cell membranes
become oxidized and are thus damaged. This cell damage has been implicated
in cancer, aging, traumatic head injury, atherosclerosis and stroke, to name a
few .13"15 Figure 1.1 illustrates the reactions for oxidative damage to cell
membrane lipids that occur during peroxidation. In this figure LH represents
oxidizable lipid and LOO', the highly reactive lipid peroxyl radical resulting from

o

Figure 1.1. Oxidation of the phospholipid fatty acyl side chain.
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oxidative attack. Note that it is the unsaturated fatty acyl side chains of the
phospholipids in the bilayer membrane that are attacked by free radicals. In
particular, it is the bis-allylic hydrogen atoms that are abstracted by lipid peroxyl
radicals to produce LOOH and lipid alkyl radical (L'), thus propagating further
oxidative dam age.16
Free radicals have been shown to be involved in inflammation.1718 Human
phagocytes are cells which engulf and destroy cells foreign to the body, such as
bacteria. Part of the process of destroying these foreign materials is through the
use of superoxide, generated by the one-electron reduction of singlet oxygen by
NADPH to yield NADPV9
During inflammation phagocytes tend to produce far more superoxide than
necessary.520 Some of this superoxide can react with protons to form H20 2. and
0 2 (eq 1.1).11 Though H20 2 alone is not highly reactive, the presence of iron

0 2-

+ 2H+ -> H20 2 + 0 2

(1.1)

can initiate lipid peroxidation which damages tissues surrounding the inflammed
area.21
Iron-dependent lipid peroxidation can be initiated by several mechanisms.22
First of all, Fe" can undergo autoxidation to Fe"1to form superoxide (eq 1.2).
The reverse reaction does occur, but it must compete with the dismutation of
superoxide by superoxide dismutase to form H20 2. Fe" also reacts with H20 2,
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Fe"

+ 02

-----------**

Fe'"

+

0 2'

(1.2)

however, by one of the following mechanisms (eqs 1.3,1.4). In this case, ’OH
and Fe'"OH serve as powerful oxidants for initiating oxidation. Thus, with only

Fe"

+ H20 2 ------------**

Fe'"

+

Fe"

+ H20 2 ------------► Fe'"OH

‘OH
+

+ OH'

OH'

(1.3)
(1.4)

trace amounts of iron in biological systems, the iron-catalyzed Haber-Weiss
reaction (equations 1.5,1.6) may occur.

Fe'"

+

0 2"

►

Fe"

+

02

Fe"

+

H20 2 -----------► Fe"'

+

'OH

(1.5)
+O H '

(1.6)

Iron can additionally react with lipid hydroperoxide (LOOH) formed during
lipid peroxidation (Figure 1.1) to produce either the lipid alkoxyl radical (LO’) or
lipia peroxyl radical (LOO‘), shown in equations 1.7 and 1.8. The resulting lipid
peroxyl radical and lipid alkoxyl radical can then react with more lipid to

LOOH + Fe" -----------►

LO*

LOOH + Fe"1 -----------► LOO’

+

OH'

+

Fe"

+ Fe"'

(1.7)
(1.8)
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6
produce LOOH or LOH and lipid alkyl radical, propagating the chain of free
radical damage to cell membranes (eqs 1.9,1.10).

LO'

+

LH

---------- ►

LOO* +

LH

►

LOH

+

L’

(1.9)

LOOH

+

L'

(1.10)

Following traumatic injury, various biological reactions occur that ultimately
result in the proliferation of a large number of free radicals. Traumatic injury
such as that to the central nervous system eventually results in a condition
known as ischemia.22 Ischemia is the partial or complete depletion of oxygen to
a tissue. Following the onset of ischemia a number of cellular metabolic
activities begin to occur which are conducive to the formation of oxygen free
radicals. Due to its lack of oxygen, the cell first switches to anaerobic
respiration.23 As this respiratory pathway is energetically less efficient, the
levels of ATP decrease dramatically. All available high energy phosphates are
consumed.23 Due to the onset of anaerobic respiration, the levels of lactic acid
(a by-product of this process) in the tissues increase.24 Tissue pH thus falls
from approximately 7.4 to between 5.9 and 6 .4 .25
As ATP is consumed in the ischemic tissue, AMP begins to accumulate and is
eventually degraded to hypoxanthine.24 Hypoxanthine in normal tissues is
converted to uric acid by xanthine dehydrogenase.26 During ischemia, however,
xanthine dehydrogenase is converted proteolytically to xanthine oxidase.27 The
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xanthine oxidase thus formed catalyzes the production of superoxide via the
oxidation of hypoxanthine to produce xanthine (Figure 1.2).28 The resulting

20» HzO

o
II

20?*,2H*

2 0 * HzO

20r ',2H*

0

II

xanthine oxidase

0

Hypoxanthine

Xanthine

Uric Acid

Figure 1.2. Mechanism of superoxide production by xanthine oxidase.
xanthine can again be oxidized by xanthine oxidase to produce uric acid and
more superoxide, or eventually, H20 2. 28
After the development of these cellular activities return of oxygen to the
tissue results in a proliferation of superoxide and H20 2 production. 22,27 The
inevitable consequence is thus lipid peroxidation and tissue damage.
Recently, free radical research has focused on another free radical called
nitric oxide, NO', shown to be important to the body. It was discovered that nitric
oxide is the vasodilator that relaxes smooth muscle in the vessel wall to
consequently reduce blood pressure. 29,30 It is also important to various other
biological functions such as neurotransmission, blood clotting, learning and
memory. 29,30Though nitric oxide is a relatively unreactive free radical, it can
react with superoxide to produce the highly reactive peroxynitrite radical, shown
in eq 11.31-33This highly reactive free radical has been implicated in oxidative
damage to membrane lip id s,34 sulfhydryl amino acids,35and methionine
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NO- + 0 2- --------- ► ONOO

.1 1)

residues.36 It has also been shown to hydroxylate and nitrate aromatic amino
acids.37,38

1.2. Antioxidation in vivo.
Antioxidants are compounds the body uses to eliminate free radicals.
Antioxidants are divided into two basic classes based on their mechanism of
inhibition. Antioxidants which prevent the initiation of oxidation are called
primary or preventive antioxidants.39 Secondary or chain-breaking antioxidants
are those which terminate chain-propagating free radicals, such as the peroxyl
radical.39
A number of enzymes exist in vivo to prevent lipid oxidation. One of these is
superoxide dismutase (SOD). SOD converts superoxide into the less reactive
H20 2l as shown in eq. 1.12 below. 40 The hydrogen peroxide is then eliminated

O r' + 2H*

s0°

► h 202 ♦ 02

(1 12)

by one of two enzymes - catalase and glutathione peroxidase. Catalase reacts
with H20 2 to produce H20 and 0 2 (eq 1.13).7,9 Glutathione peroxidase reacts
with H20 2 in the presence of glutathione (GSH) to produce H20 and oxidized
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2H202

catala-se »• 2H20

+ 02

(1.13)

glutathione (GSSG), as shown in Figure 1.3.741 Glutathione peroxidase has also
been shown to reduce lipid hydroperoxides, formed during lipid peroxidation, to

Figure 1.3. Mechanism of reduction of H20 2 via the oxidation of glutathione
by glutathione peroxidase.
the less reactive alcohol. Selenium is often considered an antioxidant, because
it is important to the function of glutathione peroxidase. 42 The oxidized
glutathione species (GSSG) is then converted back to glutathione by glutathione
reductase via the oxidation of NADPH to NADP+ (Figure 1.4 ).7,41

?

glutathione reductase

Figure 1.4. Reduction of oxidized glutathione by glutathione reductase.
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The body possesses chelating glycoproteins which usually keep iron and
copper in forms which are not conducive to the initiation of lipid oxidation. Iron,
for example, is transported through plasma bound to the protein transferrin.43
Copper, capable of initiating oxidation by a similar mechanism as Fe, is carried
through plasma by the protein ceruloplasmin.44 In these bound forms, the metal
ions are not available for initiating free radical reactions.
The body also requires other non-enzymatic natural antioxidants normally
present in healthy d ie ts.13-45'47 One such antioxidant is a-tocopherol (one of a
group of tocopherols collectively known as Vitamin E). Antioxidants such as
a-tocopherol (a-T) are compounds capable of inhibiting the oxidative chain of
reactions and are thus biologically important. During typical inhibition of lipid
peroxidation by a phenolic antioxidant such as a-T, LOO’ abstracts a H-atom
from the antioxidant to produce a stable and persistent free radical called a
phenoxyl radical (Figure 1.5).48The phenoxyl radical can then react with
another lipid peroxyl radical to produce several possible non-radical products,

ho.

CHj
+ LOO*

Figure 1.5. Mechanism for antioxidation by a-tocopherol.

one of which is illustrated above.48 BHT (butylated hydroxytoluene), also a
phenolic antioxidant, is a food additive used to prevent the oxidation of food
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which causes rancidification.49 Its antioxidant activity is believed to proceed by
the same mechanism as a-T.
Ascorbic acid (Vitamin C) is a water-soluble antioxidant. It has been shown
to react with H20 2 to produce dehydroascorbate.90 It was shown that a-T and
ascorbic acid are synergistic antioxidants, in that the ascorbic acid regenerates
the oxidized a-T into a usable form .5152
Various lipid-soluble carotenoids of plant origin, including (3-carotene (the
biological precursor to Vitamin A) have been shown to inhibit lipid oxidation in
LDL (low density lipoprotein).53 Characterization of the oxidation products of
related carotenoids suggests that the inhibition by (3-carotene is probably due to
its coupling to lipid peroxyl radicals to form non-radical products. 54

1.3. Kinetic Modeling of lipid peroxidation and its antioxidation.
Important to the study of lipid peroxidation is the use of membrane models.
Simple and uncomplicated, biologically realistic membrane models allow for a
quick and easy elucidation of many aspects of both lipid peroxidation and its
antioxidation. These include the interpretation of the kinetics of lipid
peroxidation and evaluation of the effectiveness of antioxidants. Figure 1.2
shows the structure of two membrane models, liposomes and micelles.
Surfactants such as sodium dodecyl sulfate are conical in structure and
preferentially assume a spherical micellar structure when placed in aqueous
solution.55 Phospholipids are tubular in shape and tend to form a bilayer
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Liposomes

Micelles

Figure 1.6. Structures of micelles and liposomes.

structure when placed in aqueous solution.55 They align themselves as to
minimize contact between the hydrophobic hydrocarbon side chains and the
aqueous layer.55 This bilayer structure is similar to the lipid bilayer of cell
membranes. The hydrocarbon tails of the bilayer sheet thus formed further
minimize their contact with water by folding back on themselves to form a hollow
vesicle known as a liposome.55
Liposomes can be classified as either unilamellar vesicles (ULVs) or
multilamellar vesicles (MLVs), both of varying sizes. The two liposome models
studied here are the medium-sized ULVs and large MLVs. As shown in Figure
3.3, unilamellar vesicles contain only one lipid bilayer, while MLVs contain
several stacked or concentric lipid bilayers. Between micelles, ULVs, and MLVs,
ULVs are structurally the most biologically similar to the cell membrane.
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Unilamellar Vesicles
(ULVs)

Multilamellar Vesicles
(MLVs)

Figure 1.7. Liposomal membrane models.

Systematic kinetic work done in homogeneous solution has elicited the
reactions shown in equations 1.14-1.19. 56,57These are the reactions proven to
occur during lipid peroxidation initiated by an azo compound (R-N=N-R) in
organic solution. 58,59Azo compounds are a convenient source of initiating free
radicals, in this case alkyl radicals (R'). Oxidizable substrate (e.g., linoleic acid)
is represented here by LH. The first three equations are those for initiation.

In

these reactions the azo compound decomposes into two alkyl radicals that can
react with a polyunsaturated fatty acid (linoleic acid) to produce lipid alkyl
radicals. These lipid alkyl radicals further react with oxygen in aerobic
conditions to produce lipid peroxyl radicals.
This dissertation suggests that some of the membrane models, such as
micelles and homogeneous solutions of lipid, used previously by other
investigators51,58,6&82 are not suitable model systems. Firstly, the two are not
structurally similar to the cell membrane’s lipid bilayer. Most importantly, the
kinetics of these two systems are not the same as those of the more biologically
realistic membrane models studied here - liposomes58,6M5
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Initiation
R-N=N-R

-»

2R* + N2

(1.14)

R + LH

-►

RH + L

(1.15)

R + 02

->

ROO’

(1.16)

Propagation
LOO' + LH -►

LOOH + L

(1.17)

L + 02

LOO'

(1.18)

Termination
2LO O ->

Non-radical products

(1.19)

Figure 1.5, shown previously in section 1.2, gives an example of H-atom
abstraction from a-tocopherol, a phenolic antioxidant, to produce a stable
phenoxyl radical. The phenoxyl radical then reacts with a second LOO‘ to
produce one of a variety of non-radical products, one of which is illustrated in
Figure 1.5. 48The initial H-atom abstraction is the slow, rate-determining step.59
The rate constant for this step, kjnh, determines the effectiveness of
antioxidants.59 Previous investigators have used this constant, k^, to compare
the efficiencies of various antioxidants in a variety of membrane models. 5862-6Ma
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1.4. Release of free fatty acids in lipid peroxidation.
As mentioned earlier in section 1.1, a large amount of superoxide and other
free radicals are produced during inflammation. It is commonly believed that
free radicals and prostaglandins are involved in the inflammatory process.1718
Free radical insult has been shown to stimulate phospholipases to degrade
phospholipids, liberating free fatty acids (FFA).89 Marion and Wolfe used
radiolabeled arachidonic acid to determine the source of unesterified FFA in rat
forebrain post-mortem.70They determined that it came from a variety of lipid
sources, including phosphatidylcholine and phosphatidylinositol.
Phosphatidylcholine and phosphatidylethanolamine are degraded by
phospholipase A2 to generate arachidonic acid, the predominate FFA observed
in rat brain tissues following in sult.71After the release of FFA from the
phospholipid bilayer, cyclooxygenase converts the arachidonic acid to
prostaglandins and lipid peroxides.18,72 Alternatively, lipoxygenase converts the
arachidonic acid to hydroxy fatty acids and leukotrienes.18,72 Once introduced
into cell cultures and tissues, arachidonic acid has been shown to disrupt
membrane integrity. 68,7274

1.5. The antioxidant efficiency of the synthetic CNS antioxidant U74006.
It is estimated that each year 1 million Americans suffer from stroke or trauma
to the head or spinal cord

Because no successful therapy exists as yet for

these central nervous system (CNS)-related injuries, much research into this
area is currently underway.
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In traumatic CNS injury, the initial insult results in a tearing of the neurons
and axons, resulting in death of the affected cells.22 At some point after this
occurs, there is a loss of blood flow to the brain or spinal cord tissue, a condition
known as ischemia. 75,76The reintroduction of blood flow and oxygen to this
tissue, however, results in a sudden burst of oxygen free radicals and thus, lipid
peroxidation.77 The CNS is particularly prone to oxidative damage due to the
large percentage of unsaturated lipids that make up the neuronal cell
membranes.22There is reportedly also a lack of cellular antioxidants, including
catalase and glutathione peroxidase, in CNS tissue.7,78 Because of its inability to
regenerate itself, any damage to CNS tissue results in permanent loss of cell
and tissue function. Much effort has thus been exerted into developing new
antioxidants to defend against free radical oxidative damage.
Initially, it was observed that large doses of steroids such as
methylprednisolone (Figure 1.8) inhibited lipid peroxidation in CNS tissues. It
was shown that administration of this drug improves recovery from damage to
the CNS in m ice79 and in cats.80 The problem associated with the use of these
drugs is that they are known to elicit glucocorticoid activity, including
hormonally-related elevation of blood glucose levels; immunosuppression, and
weight lo ss.81
More recently, a new, but similar class of antioxidants called 21aminosteroids has been developed that lack this glucocorticoid activity.82Two
representative compounds from this class include U74500A (pregna-1,4,9(11 )triene-3,20-dione, 21 -[4-[5,6-bis(diethylamino)-2-pyridinyl]-1 -piperazinyl-16-
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Na
HQ

...OH

Figure 1.8. Structure of methylprednisoione.

methyl-,hydrochloride) and U74006F (21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)1-piperazinyl]-16-methyl-( 16. alpha. )-pregna-1,4,9(11 )-triene-3,20-dione
monomethanesulfonate mesylate) shown in Figure 1.9. Both contain a
nonglucocorticoid steroid bound to an amine which serves as its antioxidant
functionality. W hile very similar in structure, the two inhibit lipid peroxidation by
different mechanisms. The U74500A is an iron chelator and thus inhibits irondependent lipid peroxidation. 83,84 U74006F, though not an iron chelator, is
capable of inhibiting both iron- and noniron-dependent lipid peroxidation.83,84
Certain pyridine compounds were shown to have affinity for F e".85These
compounds contain a N-C-C-N fragment that enable them form bidentate ligands
to the m etal.86 Similarly, U74500A contains a N-C-C-N fragment that renders it
an excellent chelator of Fe". As such, it is capable of inhibiting Fe"-dependent
lipid peroxidation.87 Interestingly, this amine was less effective at inhibiting
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U74500A

U74006F

Figure 1.9. Structures of 21-aminosteroids in clinical trials.

oxidation when not bound to the steroid.86Although most of the iron added to
lipid systems is located within the more aqueous region of the membrane, it has
been found that iron can actually bind to the membrane itse lf.88 Steroids,
including the 21-aminosteroids, are already known to partition themselves within
the lipophilic region of the membrane. 89,90The fact that addition of a steroid to an
iron chelator was capable of increasing its ability to inhibit iron-dependent
oxidation could suggest that the membrane-bound iron is the actual initiating
species.
U74006F prevents lipid peroxidation but is not an iron chelator. It was shown
to exhibit inhibition comparable to a-tocopherol in membranes.91 Both U74006F
and U74500A were proven reactive toward lipid peroxyl radicals (LOO‘) and
phenoxyl radicals (PhO‘) , 91 and were able to spare a-tocopherol in membrane

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

19
models as well as in vivo. 91,92An interesting finding was that U74006Fshowed a
smaller antioxidant effectiveness in systems of arachidonic acid in ethanol than
in membranes.91 Perhaps the antioxidant role of U74006F includes membrane
stabilization by the steroid group. This 21-aminosteroid was in fact shown to
elicit similar effects as cholesterol on lipid packing order in membrane m odels.90
In this study, U74006F was proven to have a wide distribution between the two
layers and contributed to a higher order in lipid packing within the hydrophobic
lipid domain. Higher order and increased membrane packing may result in the
entry of fewer free radicals into the lipid bilayer to initiate oxidation.
U74006F was chosen for development in clinical trials for antioxidant
protection against brain and spinal cord injury, stroke, and brain hemorrhage.93
Although U74500A in some instances was proven to be a more potent inhibitor
of iron-dependent lipid peroxidation, it lacks pharmaceutic stability and is rapidly
eliminated in vivo. 93 It was for these reasons that we chose U74006F for our
investigation.

1.6. Goals for this research.
The first goal of this study was to compare the kinetics of homogeneous
solution82 and micelles 58,66with that of liposomes, whose lipid bilayer makes for
a better model of the cell membrane. The data and results for work done in this
area are described in detail in chapter 2. The kinetics of the two liposome
models presented here, multilamellar vesicles (MLVs) and unilamellar vesicles
(ULVs), are further compared. Results from these data show that the
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traditionally accepted rate equation determined for homogeneous solution and
for micelles is not valid in either of the liposome models studied here.
Secondly, the antioxidant effectiveness of a-tocopherol was determined for
micelles and for MLVs and ULVs. The results are compared to that observed by
others in the same or different systems. The data show that the effectiveness of
a-tocopherol decreases from homogeneous solution and micelles to liposomes.
This indicates that as the membrane model becomes more biologically realistic,
the antioxidant effectiveness of a-tocopherol decreases. This could suggest that
a-tocopherol may not actually be very effective in vivo. It was also observed that
the antioxidant was less effective at high concentrations. This, in conjunction
with findings by other researchers, may suggest that at high concentrations there
is a competition between antioxidation and prooxidation by a-tocopherol.
The third goal of this research was to determine the role of free fatty acids in
lipid oxidation and antioxidation. In chapter 3 we present data that clearly show
there is an increase in the antioxidant efficiency of a-tocopherol in the presence
of FFA. This effect becomes important in oxidatively damaged tissue where FFA
have been shown to be released. 70,94,95
Evidence from differential scanning calorimetry (also in chapter 3) is
presented here that suggests there is a change in membrane fluidity when both
a-T and FFA are present. It is possible that an increase in membrane fluidity in
the presence of FFA is responsible for the increase in a-T s efficiency in
liposomes containing FFA. A more fluid membrane may allow for greater
mobility of a-tocopherol to encounter and trap free radicals.
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Finally, the antioxidant effectiveness of U74006F was compared with that of
a-tocopherol in systems of noniron-dependent lipid peroxidation in ULV
liposomes. These data are presented in chapter 4. Results show that there is a
decrease in the antioxidant effectiveness of U74006 between pH 7.0 and pH 6.5.
This could indicate that U74006 may not be effective in damaged tissue, where
the pH was shown to decrease to about 5.4-6.9.25
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CHAPTER 2: EFFECT OF MEMBRANE STRUCTURE ON THE
KINETICS OF LIPID PEROXIDATION

22
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2.1. INTRODUCTION
Systematic kinetic work done in homogeneous solution has elicited the
following reactions (eqs 2.1 >2.6), given previously in chapter 1 but repeated here
for convenience59 These are the reactions generally believed to occur during
lipid peroxidation initiated by an azo compound (R-N=N-R) in organic
solution.5859 Oxidizable substrate (e.g., linoleic acid) is represented here by LH.

Initiation
R-N=N-R

-»

2R + N2

(2.1)

R + LH

-►

RH + L

(2.2)

R + 02

-►

ROO'

(2.3)

LOOH + L

(2.4)

LOO*

(2.5)

-> Non-radical products

(2.6)

Propagation
LOO* + LH

L + 02

->

-*

Termination
2LOO
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The first three equations are those for initiation.

In these reactions the azo

compound decomposes into two alkyl radicals that can react with a
polyunsaturated fatty acid (linoleic acid) to produce lipid alkyl radicals. These
lipid alkyl radicals further react with oxygen in aerobic conditions to produce lipid
peroxyl radicals.
Most common biological initiators of membrane lipid peroxidation, for
example, the hydroxyl radical from the metal-mediated reduction of hydrogen
peroxide or superoxide, are hydrophilic.7,11 These initiating free radicals form in
the extracellular medium or at the membrane interface between the lipophilic
and hydrophilic regions.711 Thus, the radicals must partition into the lipophilic
region of the membrane at least slightly in order to abstract a reactive bis-allylic
lipid hydrogen atom and initiate the lipid peroxidation chain process.16
In this study, we have used the cationic, water-soluble azo compound ABAP
(2,2’-azobis-2-amidinopropane dihydrochloride), shown in Figure 2.1, to mimic
the hydrophilic nature of most biological initiators. Azo compounds are known to
decompose unimolecularly at a known and constant rate.96The decomposition
of the azo initiator is thus quantitative, making interpretion of the kinetic results
feasible.58 Many researchers have used ABAP as an initiator in in vitro models
for membrane lipid peroxidation because of its ease of study. 58,66,97 One
assumption that is commonly made is that the mechanism of the ABAP
decomposition is similar to that observed with other azo compounds
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"Cl!

Figure 2.1. Structure of ABAP, a water-soluble azo initiator.

(see eqs 2.7-2.9).58 The first step results in the formation of a caged radical
complex via either concerted or stepwise bond dissociation (eq 2 .7 ).5896The
caged radicals can then either combine in the cage (eq 2.8) or escape as free
radicals available for initiating chain processes (eq 2.9).

R N =N —R --------►

R* N = N R '

R- N =N R '

(2.7)

R—R

+

N2

(2.8)
(2.9)

Previous studies probing the kinetics of lipid oxidation in homogeneous
solution and in SDS micelles elucidated the rate equation shown in eq 2.10.57
The rate constants denoted in this equation are those for the free radical

(2 . 10)
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oxidation reactions described in eqs 2.1-2.6. Here, kp is the rate constant for
initiation (eq 2.4), k* is the rate constant for termination (eq 2.6), R, is the rate of
initiation (eq 2.1), and LH is the oxidizable substrate (polyunsaturated fatty acid).
More recently, liposomes are being used as membrane models, because
their lipid bilayers make for a better model of the cell membrane.98 In aqueous
solution, two types of liposomes are possible, multilamellar vesicles (MLVs) and
unilamellar vesicles (ULVs). Unilamellar vesicles are phospholipid spheres
containing only one lipid bilayer, while MLVs contain several concentric or
stacked lipid bilayers. ULVs are a more biologically realistic model of the cell
membrane’s lipid bilayer.
The goal of this study was to determine whether homogeneous kinetics
applied to more biologically realistic membrane models such as liposomes. The
results obtained for SDS micelles were compared to results reported in the
literature for the same system to confirm that the method used here for
measuring lipid oxidation was valid. Furthermore, comparison of the kinetic data
obtained for the ULV and MLV membrane models studied here with data
reported in the literature show that indeed the kinetics of these two systems are
different from that of other previously studied model systems. Neither MLVs nor
ULVs seems to abide by the traditionally accepted rate equation.
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2.2. RESULTS
2.2.1. Medium effects on the effective rate of decomposition of ABAP, a
water-soluble azo initiator.
Rates of oxygen consumption were determined at 37°C as a function of the
concentration of ABAP (2,2' azobis-2-amidinopropane) in each of the different
media used in this study (buffer, SDS micelles, MLVs, and ULVs). No
unsaturated lipids were present in the SDS, MLV, or ULV systems. Tabulated
raw data for these experiments can be found in the Appendixes, Table A.1.
The rate of decomposition of initiator is represented below as R.. This rate
depends on the rate constant for the decomposition of the initiator, kd, and

Rj = nekd[ABAP]

(2.11)

the efficiency, e, which is the fraction of alkyl radicals that react with oxygen to
produce peroxyl radicals. The stoichiometric factor, n, is assumed to have a
value of 2, because the decomposition of azo compound results in the
production of two molecules of free radicals, in homogeneous systems, ne is
approximately equal to 1.0, and kd for ABAP is equal to 3.72X10 ‘V 1. 58 The
slope of the lines generated by least squares treatment of rates of initiation (Rj)
versus [ABAP] gives the quantity nekd (Figure 2.2). From the slope of R* versus
[ABAP] and with n equal to 2, we can calculate the quantity ekd, which is the
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Figure 2.2. Comparisons of the effect of media on the decomposition of ABAP in
A) phosphate buffer, B) SDS micelles, C) MLVs, and D) ULVs. Samples contained the following:
50mM phosphate buffer, pH 7.4,88.3 pM DTPA, B) 0.5 M SDS in phosphate buffer, 88.3 pM DTPA, C) 20
mg/mL MLV hydrogenated egg PC In phosphate buffer, 88.3 pM DTPA, D) 20 mg/mL MLV hydrogenated
egg PC in phosphate buffer, 88.3 pM DTPA. Data were obtained using the oxygen electrode method.
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effective rate of formation of radicals available for initiating lipid peroxidation
chain processes. Thus, we calculate values of ekd at 37°C (Table 2.1) of 3.1 ±
0.4 X 10‘V 1 and 2.8 ± 0.4 X 10 V 1 in the presence of buffer alone and SDS,
respectively. In MLVs and ULVs the values were similar, at 2.4 ± 0.3 X 10'7s'1
and 2.3 ± 0.2 X 10'7s'1, respectively. Calculations for comparison of the means
at 95% confidence were performed on these da ta.99These calculations show
that ekd for MLVs and ULVs is different from that of buffer. In addition, values for
ekd in micelles and buffer were statistically the same. Figure 2.3 illustrates these
results graphically.

Table 2.1. Results fo r measuring the dependence o f media on the rate o f
decom position o f ABAP in buffer, m icelles, MLVs and ULVs.*
__________
ekd ± cj (X107 s"1)
Model System
phosphate buffer
3.12 + 0.43
SDS micelles
2.83 ± 0.43
MLV hydrogenated PC
2.40 ±0.30
ULV hydrogenated PC
2.28 ±0.23
Data obtained from the slopes of the lines generated from data in Figure 2.1.

4-

0-

Buffer

Micelles MLVs
Membrsne Model

ULVs

Figure 2.3. Error associated w ith calculated values o f ekd in various
membrane models.
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2.2.2. Effect of [ABAP] on rates of oxidation in micelles, MLVs and ULVs.
Rates of oxygen consumption, R^, were determined for different
concentrations of ABAP in various membrane models, this time containing
oxidizable substrate. Experiments were done in SDS micelles containing linoleic
acid, and in ULVs and MLVs prepared from soy PC. Tabulated raw data for
these experiments can be found in Table A. 2 of the Appendixes. Log-log plots
of log(Rox) versus log([ABAP]) were constructed for each model system and are
shown in Figure 2.4. The slope of these plots gives the order for ABAP in each
of the systems. These results are tabulated in Table 2.2.

Table 2.2. Results obtained for measuring the order in ABAP for SDS,
MLVs, and ULVs.*______________________________________________
Membrane Model
Order+ ct
SDS micelles
MLVs
ULVs

0.43 ± 0.02
1.37 ±0.10
1.35 + 0.18

* Data were obtained for slopes of lines generated in the graphs in Figure 2.2.

2.2.3. Effect of the concentration of unsaturated lipid, [LH], on the rate of
oxidation in micelles, MLVs, and ULVs.
Log-log plots were constructed for data collected in systems containing
varying concentrations of MLV and ULV soy PC diluted with 20 mg/mL
hydrogenated egg PC (unoxidizable lipid) (Figure 2.5, with tabulated raw data in
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Figure 2.4. Decomposition of ABAP in various membrane models containing unsaturated lipid.
Varying concentrations of ABAP (0-15 mM) were added to samples containing A) 0.5 M SDS micelles in phosphate buffer,
88.3 pM DTPA, 46.7 mM linoleic acid, B) 20 mg/mL MLV soy PC in buffer, 88.3 pM DTPA, C) 20 mg/mL ULV soy PC in
88.4 buffer, 88.3 pM DTPA. Data were obtained using the oxygen electrode method.
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Figure 2.5. Effect of varying oxidizable substrate
concentration on the rate of decomposition of ABAP in
A) MLVs, and in B) ULVs. Both systems contained varying
amounts of soy PC diluted with 20 mg/mL hydrogenated egg PC in 50
mM phosphate buffer, pH 7.4,88.3 nM DTPA, and 21.2 mM ABAP.
Rates of oxidation were measured using the oxygen electrode method.
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Table A. 3 of the Appendixes). The slope of this line gives the order in LH.
Results show that the order in both systems is less than 1 (Table 2.3). The two
systems appear to be kineticaiiy different, in that the calculated order in MLVs
(0.76 ±0.10) is significantly different from the order in ULVs (0.17 ± 0.10).
Calculations for comparison of the means at 95% confidence99 show that the two
values for the order in LH are stastically different.

Table 2.3. Results for measuring the order in LH in MLVs and ULVs.*_____
Membrane Models
Order ± o
MLVs
0.76 ±0.10
______________ ULVs__________________________ 0.17 ±0.10___________
* Data were obtained from the slopes of the lines generated from the data in Figure 2.3.

2.2.4. Effect of [OJ on rates of oxidation in MLVs and ULVs.
The effect of oxygen concentration on rates of oxidation in MLVs and ULVs is
shown in Figure 2.6. Rates of oxygen consumption were determined in both
MLVs and ULVs containing oxygen concentrations of 62.5, 250 and 1250 pM.
Tabulated raw data from this study can be found in the Appendices in
Table A. 5. Log-log plots were constructed using rates of oxidation and [O2 ]
(Figure 2.6). The slope of the line generated by least squares for the MLV
system 0.09 ± 0.05 was greater than that for the ULV system, 0.05 ± 0.01 (Table
2.4). Calculations for comparison of the means at 95% confidence99 show that
these two numbers are not different. Using this same calculation, however, the
two orders in 0 2 for the same two systems is statistically different from zero.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

-

6.8

6.9-

o>

-7.0-

■ MLVs
slope ■ 0.09 ± 0.05

-7.1-

▲ ULVs
slope = 0.05 ± 0.01

-4.3

-4.1

-3.9

-3.7

-3.5

-3.3

-3.1

-2.9

log[02]
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Table 2.4. Results for measuring the order in [OJ in MLVs end ULVs.
Membrane Model
Order ± a
MLVs
0.09 ±0.05
_____________ ULVs__________________________ 0.05 ±0.01
* Data were obtained from siopes of ihe lines generated from the data in Figure 2.6.

2.3. DISCUSSION
2.3.1. Rate of intiation resulting from ABAP decomposition in micelles,
MLVs and ULVs.
It has often been assumed that the decomposition chemistry and kinetics of
ABAP are essentially independent of its environment.10a101 The results
presented here tend to suggest that such assumptions are not always justified.
Apparently, SDS micelles (containing no oxidizable substrate) do not have an
appreciable effect on ABAP decomposition; the product of the rate constant for
decomposition and the efficiency is the statistically the same in this system as in
buffer alone (Figure 2.2). Statistical analysis of data do show, however, that the
decomposition of ABAP in MLVs and ULVs (also containing no oxidizable
substrate) is different from its decomposition in buffer alone.
Strickland, Pryor, et a l56 reports a value of kd equal to 3.7 X 10'7s'1 for ABAP
in micelles. Using the value of e they reported, 0.49, kd is thus calculated to be
5.7 X 10*7 s'1. From the slopes of the lines shown in Figure 2.1 and assuming
the stoichimetric factor n equal to 2, ekd was calculated. The results are
presented in Table 2.1. These results show that the rates of decomposition of
ABAP in MLVs and ULVs are different from the rates of decomposition in buffer
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and micelles. The decomposition of ABAP thus does not appear to be
independent of the environment or media.
The order in LH was determined by measuring the rates of oxidation for
varying concentrations of unsaturated lipid (Table 2.3). The orders in LH for
MLVs and ULVs are statistically different and are different from 1, the order in
LH for homogeneous solution.
Barclay, et al, have reported attempts at elucidating the kinetics of azoinitiated liposome system s.102They argue that the rate law confirmed for
homogeneous systems (determined for eqs 2.1-2.6 and given in eq 2.10) holds
for liposomes, since they were able to calculate an order of 1.07 in LH and 0.54
in ABAP. There are two problems with these data. First of all, the order in
ABAP was calculated in MLVs prepared by vortex-stirring followed by freezethaw. The order in LH, on the other hand, was determined in ULVs prepared by
passing the liposomes through a French pressure cell. The first problem with
Barclay’s experiments is that he assumes the kinetics of ULVs and MLVs are the
same. The results presented here show a large difference in the kinetics of ULV
and MLV systems. The second problem with Barclay’s study is that the ULVs
prepared using the French pressure cell are very small, on the order of 15-30
nm 103. The liposomes prepared using the extrusion method, as was utilized
here, are much larger, with a diameter of about 70 nm 1M. The kinetics of these
two systems should therefore be different, since the fluidity of the liposome
system decreases as the size of the ULV increases.105'108As will be discussed in
chapter 3, fluidity of the membrane model has a large effect on the kinetics of
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the system. The small ULVs prepared by Barclay and his coworkers would thus
be more fluid and more kinetically similar to homogeneous solution.
In summary, it is likely that the kinetics for oxidation in MLVs and ULVs are
quite different. This work also suggests that the traditional rate equation
reported for homogeneous solution and for micelles does not necessarily apply
to liposomes.

2.4. EXPERIMENTAL
2.4.1. Materials.
Linoleic acid (cis.cis-9, 12, octadecadienoic acid) and
diethylenetriaminepenta-acetic acid (DTPA) were obtained from Sigma
Chemical Co. Hydrogenated L-a-phosphatidylcholine from frozen egg yolk was
purchased from Avanti Polar Lipids (Alabaster, AL). A convenient and
inexpensive source for the soy phosphatidylcholine used in this study was found
to be commercial L-<x-Lecithin capsules, purified as described below. Granular
2,2' azobis-2-amidinopropane dihydrochloride (ABAP), type V-50, was obtained
from Wako Pure Chemical Industries, Ltd. These, and all other incidental
chemicals and solvents, were of high purity and were used as received.

2.4.1.1. Purification of L,a lecithin.
The flash chromatography column apparatus was obtained from Ace Glass,
Inc. (cat. no. 5872). It consisted of a column with a 10 mm I.D. and a 45.7 cm
effective length, a 250 mL reservoir, and a flow control adapter. A chloroform
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slurry containing 40 g silica gel was poured into the column such that the column
bed was 35-37 cm in length.
One iecitnin capsuie was dissolved in 10 mL chioroform and ioaded onto the
column. The column was then pressurized using nitrogen (> 10 psi) such that
the flow rate was approximately 10 mL/min. The column was first eluted with 400
mL ethyl acetate/methanol (50:50). This fraction presumably contained less
polar compounds such as a - tocopherol, (3 - carotene, and diglycerides. The
PC was then eluted off the column using 200 mL methanol. The methanoiic
solution was evaporated to dryness under vacuum leaving the purified lipid as a
thin film on the walls of the flask. The yield was approximately 200 ± 75 mg,
depending on the source of lecithin. The purified material was dissolved in
chloroform and was stored under nitrogen at -20°C.

2.4.1.2. Analysis of the purified phosphatidylcholine.
The purity of the sample was confirmed using reverse-phase HPLC and
comparison to a 99% soy PC sample. A Perkin-Elmer Series 410 pump with a
235C diode array detector were used. The column used was a Spherisorb 25
cm X 4.6 mm I.D. Cs reverse-phase column with 5 pm particle size (Regis, 8210
Austin St., Morton Grove, IL, 60053). A solvent mixture consisting of 90%
acetonitrile and 10% water was formed using the HPLC pump. Conditions for
the separation included a 1.0 mL/min flow rate run isocratically at 25°C and UV
detection at 215 nm. Data were collected and analyzed using LabCalc software
(Galactic Industries).
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The HPLC chromatograms obtained for the soy PC purified as described
above and for a commerical sample of soy PC (99% purity) are shown in Figure
2.7. Both chromatograms show a similar group of peaks that elute from 14-23
min. These peaks reflect the mixture of phosphatidylcholines having various
fatty acid composition (probably of varying degrees of unsaturation). One
additional large peak was observed at 26.5 min in the commercial soy PC
sample that was not observed in the purified soy PC. In addition, several small
impurity peaks were observed between 5 and 15 min in the commercial sample
that were not observed for the chromatographically purified PC. The peak
eluting at 3 min in both samples was shown to be due to solvent passage.
Based on the HPLC analysis, it appears that the PC purified by this method is of
higher purity than PC obtained commercially. However, note that the size of the
peaks observed with UV detection is not directly indicative of the quantity of
material present.109,110
Fast-atom bombardment-mass spectra (FAB-MS) were aquired using a
Finnigan MAT TSQ - 70 triple quadrapole mass spectrometer with an Antek PS4 cesium ion gun. Samples were applied to both glycerol and 3-nitrobenzyi
alcohol matrices and each were run separately. Sample mixing was
accomplished by placing the matrix material on a stainless steel probe tip and
applying the sample to the matrix. The heater current for the Cs pellet was run
at 150 pA, the extractor at 2.5 kV, the focussing lens at 5.5 kV, and the
acceleration voltage at 6.4 kV.
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Figure 2.7. HPLC chromatogram fo r L-aphosphatidylcholine. Samples contained A) 100 mg/mL
chloroform solution of 99% L-a-phosphatidylcholine, and B) 20
mg/mL chloroform solution of L-a-phosphatidylcholine purified
from lecithin.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

41
The chromatographically-purified soy PC, Figure 2.8, gave FAB-MS that
show mass clusters centered at 695.9, 717.9, 739.0, 759.1, 783.2, and 805.2
m/e while the commercial soy PC sample showed mass clusters centered at
759.1 and 783.1 m/e.
Table 2.5 shows the fatty acid composition of some common phospholipids,
including PC extracted from soybean. Possible combinations for fatty acyl side
chains that wouid have combined masses corresponding to the mass clusters
observed by FAB-MS were calculated (Table 2.6). The presence of the cluster

Table 2.5. Fatty acid com position of commonly used p h o sp h o lip id s55
Percent abundance (%) in
Fatty acid
Common
natural source o f PC
abbreviation
name
Egg PC
Soy PC
Rat PC
14:0
myristic
16:0
palmitic
17.2
35.3
28.8
3.8
18:0
stearic
13.5
18.0
oleic
22.6
26.8
8.4
18:1
47.8
19.4
18:2
linoleic
5.7
18:3
linolenic
8.6
0.2
1.0
20:3
1.0
17.0
20:4
arachidonic
3.6
2.4
20:5
1.5
22:5
1.3
3.5
22:6
12.6

at 805.2 m/e in the FAB-MS of the purified soy PC indicates that this sample
contained more arachidonic acid (20:4) than did the commercial sample. Since
no arachidonic acid should be present in soy PC (Table 2.5), PC from some
other source may have been added to the commercial lecithin capsules. The
peak with mass 717.9 m/e for the purified lecithin is likely another phospholipid
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Figure 2.8. FAB-MS obtained fo r A) 99% L-a-phosphatidylcholine, and B)
L-a-phosphatidylcholine purified from a lecithin capsule.
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Table 2.6. Possible combinations of Ri, R2for the observed FAB-MS mass
clusters.
Possible Ri, R2
Mass cluster
Mass
combinations
759.1

16:0/18:0
16:0/18:1
16:0/18:2
16:0/18:3

761
759
757
755

783.1

18:0/18:1
18:0/18:2
18:0/18:3
18:1/18:2
18:1/18:3
18:2/18:3
18:0/18:0
18:1/18:1
18:2/18:2
18:3/18:3

789
787
785
783
785
783
781
781
779
777

805.2

20:4/18:0
20:4/18:1
20:4/18:2
20:4/18:3

809
807
805
803

of the same family but is not identified here. Note that the masses reported by
FAB-MS are one mass unit greater than the actual mass because the analyzed
species are protonated. Also, as is true of UV detection, size of the peak
produced by FAB-MS is not necessarily proportional to the quantity present.111
It is likely that the purification procedure reported here results in a purer
lecithin sample than was available in the particular commercial sample used as a
standard. Evidence of this was the appearance of the extra impurity peaks
observed in the HPLC chromatogram for the commercial sample. From the MS
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data, however, its fatty acid composition appears slightly different. Although the
FAB-MS showed that the two samples contained different types of fatty acyl side
chains, their properties should be the same.

2.4.2. Methods.
2.4.2.1. Preparation of multilamellar and unilamellar vesicles.
To produce multilamellar vesicles (MLVs) the suspension of soy PC in buffer
was sonicated in a low energy bath-type sonifier for 5 min, making sure that all
PC on the sides of the flask were in solution.112 Liposomes produced in this
manner are very large and heterogeneous in size, on the order of 0.1-5.0 pM in
diam eter.98 For unilamellar vesicles (ULVs), the sample was then extruded 10
times or until clear through 2 X 100 nm polycarbonate filters using an Avestin
liposome extrusion device (Ottawa, Canada).104 ULVs prepared using this
method have been shown to be on average about 70 pM in diam eter.104

2A.2.2. Measurement of the effect of SDS micelles and
phosphatidylcholine liposomes on the rate of decomposition of ABAP.
The rate of decomposition of ABAP was first determined in 50 mM potassium
phosphate buffer, pH 7.4. This was accomplished by placing 3 mL of the
phosphate buffer (containing 88.3 nM DTPA) in a Clark-type oxygen electrode
cell. DTPA (diethylenetriaminepenta-acetic acid ) was added to chelate any iron
present that may initiate iron-dependent lipid oxidation. The Biological Oxygen
Monitor, Model Y S I5300 (Yellow Springs Instrument Co., Yellow Springs, Ohio)
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was interfaced to computer software via a 12 bit A/D converter. Oxygen
concentration was thus followed over time. Increasing amounts of 0.5 M ABAP
in water were added (a few pL at a time), and after each addition, oxygen
concentration was followed. Rates of oxidation (R«) were determined from the
slopes of lines generated from plots of oxygen concentration versus time. A plot
of Rox versus [ABAP] was then constructed and its slope was measured.
To determine the effect of SDS micelles or PC liposomes on the rate of
decomposition of ABAP, a 3 mL solution of either 0.5 M SDS or 20 mg/mL
hydrogenated soy PC in 50 mM potassium phosphate buffer, pH 7.4, was
prepared. MLVs or ULVs were then prepared from soy PC using the methods
described previously, section 2.4.2.1. DTPA was added so that its final
concentation was 88.3 (iM. Increasing volumes of 0.5 M ABAP in water were
added (a few pL at a time), and after each addition, the rate of decrease in
oxygen concentration was followed.

2.4.2.3. Measurement of the effect of [ABAP] on rates of oxidation in SDS
micelles, MLV, and ULVs.
To determine the effect of [ABAP] on rates of oxidation in SDS micelles or soy
PC liposomes, a 3 mL solution of either 0.5 M SDS or 20 mg/mL soy PC in 50
mM potassium phosphate buffer, pH 7.4, was prepared. MLVs or ULVs were
then prepared from soy PC using the methods described in section 2.4.2.1.
DTPA was added so that its final concentation was 88.3 pM. To the samples
containing SDS, linoleic acid was added so that its final concentration was 46.7
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mM. Increasing amounts of ABAP in water were added (a few pL at a time), and
after each addition, the rates of oxidation were measured as described in section
24.2.2.

2.4.2.4. Measurement of the effect of [LH] on rates of oxidation in MLVs
and ULVs.
To determine the effect of oxidizable substrate concentration, 3 mL solutions
of varying concentrations of soy PC diluted with 20 mg/mL hydrogenated egg PC
were prepared in 50 mM potassium phosphate buffer, pH 7.4. The solutions
were then either sonicated in a sonic bath (for MLVs) or extruded (for ULVs), as
previously described. A 2.7 mL aliquot of the solution was then placed in an
oxygen electrode cell. Stock solutions DTPA and ABAP in buffer were added, so
that their final concentrations were 88.3 pM and 21.2 mM, respectively. The
concentration of oxygen was followed over time. The rates of oxidation, Rox, were
determined as described in section 2.4.2.2. Plots of the rate of oxidation versus
[LH] were constructed.

2.4.2.5. Measurement of the dependence of oxygen concentration on rates
of oxidation in MLVs and ULVs.
Solutions of 20 mg/mL ULV or MLV soy PC in phosphate buffer were
prepared as described previously. These solutions were maintained at 62.5,
250 and 1250 pM 0 2 by bubbling each with gas of varying 0 2 concentrations (5,
20, and 100%, respectively). The 5% 0 2 gas contained an 0 2/N2 mixture, the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

47
20% 0 2 gas was a typical air mixture, and the 100% gas contained pure 0 2. The
concentration of oxygen in the sample was estimated using the assumption that
air-saturated solution contains 250 nM 0 2t 113and that air itself is 20% 0 2. The
concentration of 0 2 in samples bubbled with 5% 0 2 is 62.5 pM; with 20% 0 2, 250
pM; and with 100% 0 2l 1250 pM. Stock solutions of DTPA and ABAP in
phosphate buffer were added so that their final concentrations were 88.3 pM and
21.2 mM, respectively. The rate of oxygen consumption was then measured by
oxygen electrode method.

2.4.2.6. Error analysis for the oxygen electrode method.
The oxygen electrode method described previously included error that was
associated with that of the A/D converter, solution preparation, drift of the
electrode itself, and error from imperfections in the electrode membrane. Each
of these instrumental errors analysis is listed in Table 2.7. As long as the
measurement was performed over a short period of time, all of these errors
should be very small in comparison to that derived from the imperfections in the

Table 2.7. Instrumental error associated with the oxygen electrode method.
Source of error
Percent error
A/D converter
± 0.02%
solution preparation
± 0.32%
drift of electrode
± 0.13% per 15 min
Physical imperfections in membranes_______________ ± 10%_____________
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membrane, which is reportedly 10%. Thus, the total error associated with the
use of the oxygen electrode over a 15 minute period can thus be assumed to be
±10.47%.
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CHAPTER 3: EFFECT OF FREE FATTY ACIDS AND MEMBRANE
STRUCTURE ON ANTIOXIDANT EFFICIENCY OF
a-TOCOPHEROL

49
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3.1. INTRODUCTION
As discussed in Chapter 1, the inhibition of lipid peroxidation by a phenolic
antioxidant occurs due to competition between chain propagation (eq 3.1) and
H-atom abstraction from an antioxidant (eq 3.2) to produce a stable and

LH

+

LOO'

-> L*

+ LOOH

(3.1)

ArOH

+

LOO'

-> ArO' + LOOH

(3.2)

persistent phenoxyl radical (ArO*). The phenoxyl radical can further react with a
second LOO’ to produce a non-radical product (illustrated in Chapter 1, Figure
1.1). The initial H-atom abstraction is the slow, rate-determining step. Previous
investigators measured the rate constant for this step, kjnh, in order to compare
the effectiveness of antioxidants. This constant was calculated using the rate
equation (eq 3.3) determined for inhibited oxidation in homogeneous

Ro*,™ =

kpRifLHI.
2M A rO H ]

(3.3)

solution. In order to calculate kw,, kp, the rate constant for the propagation
reaction (eq 2.4), and Ri, the rate of initiation (eq 2.1), would first have to be
experimentally determined. This problem can be alleviated by instead
calculating an antioxidant efficiency, AE. Antioxidant efficiency is
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mathematically defined as K J K and has been calculated as such in previously
reported w ork.66 The method used here to calculate AE assumes as little

LOO-

+

LOO- +

L- +

LH

ArOH

kinh»

(3.4)

LOOH

ArO - +

(3.5)

LOOH

knowledge about mechanism as possible. In these calculations the "50%
inhibition concentration" is first determined experimentally. This is the
concentration of antioxidant required to produce a 50% decrease in the rate of
oxidation. An assumption about the kinetics of the system is then made in order
to calculate AE without first calculating kw, or kp. When the rate of lipid
peroxidation is inhibited by an antioxidant by 50%, the rate of the reactions in
eqs 3.4 and 3.5 are assumed to be equal and, therefore, kp and kw, are equal. If
this assumption is accurate, then eqs 3.6 and 3.7 must also be valid. In these

kp[LH]5o[LOO-] = k,nh[LOO'][ArOH] so

kinh

kp

_

[LH]S0
[ArOHfco

(3.6)

(3.7)

equations, [LH]so and [ArOH]so represent the concentrations of oxidizable lipid
and phenolic antioxidant at 50% inhibition, respectively.
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This work demonstrates that the antioxidant efficiency (AE) calculated in this
manner for a-tocopherol decreases dramatically from homogeneous to
heterogeneous systems of lipid, such as micelles, liposomes, and microsomes.
In addition, it is concluded that free fatty acids actually enhance AE for atocopherol. This becomes important in damaged tissue, where free fatty acids
have been shown to be released. 70,94To determine what effect FFAs have on the
membrane that enhances a-tocopherol’s antioxidant efficiency, physical
characteristics of the liposome before and after addition of FFA were
investigated.
An electron spin resonance (ESR) assay was used to measure the
entrapped or internal volume of the liposome vesicle. In this assay the
liposomes were prepared containing the stable nitroxyl radical TEMPOL (Figure
3.1). Due to its membrane permeability, TEMPOL partitions both within the

OH

Figure 3.1. Structure of TEMPOL, a membrane permeable nitroxyl radical.
aqueous interior of the vesicle, as well as outside the vesicle in solution.114A
relatively membrane impermeable spin-label broadening agent,
tris(oxalato)chromate(lll), is then added. This paramagnetic ion reportedly
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remains only on the outside of the liposome115116Spin-label broadening agents
work by both spin exchange and through dipole-dipole interactions.117118 Spin
exchange occurs as a result of a contact interaction, and dipole-dipole, a
pseudocontact interaction.117118 In both cases, shorter relaxation times are the
overall result and line broadening occurs. ESR signal represented by the
extravesicular nitroxyl radical is thus broadened by the chromium oxalate (Figure
3.2). Chromium oxalate is added in increasing concentrations until no further
broadening occurs. The signal thus reaches a limiting minimum peak height in
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Figure 3.2. Method of measuring entrapped volume in liposome vesicles
using the nitroxyl radical TEMPOL and the paramagnetic ion Cr (III).

the presence of Cr (III). The signal that remains is that of the TEMPOL within
the vesicle, and the intensity of the remaining signal is manipulated to determine
entrapped or internal volume within the liposome vesicle. If the membrane
becomes leaky, signal from intravesicular TEMPOL may then become
broadened by Cr (III) that has permeated the membrane, and the effective
entrapped volume or observed signal should thus be smaller. In these studies,
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entrapped volume was determined for ULVs with and without FFAs to detect
differences in entrapped volume and/or “leakiness” of the membrane.
Differential scanning calorimetry (DSC) is often used to measure membrane
flu id ity .119-121 There are two phases that can exist in the liposome - the more
ordered gel state and the less ordered or more fluid liquid crystalline state. DSC
is used to measure the temperature of the transition from one phase to another
and the enthalpy of this transition. Shifts in the liposome’s gel to liquid crystal
transition temperature or enthalpy correlate to a change in membrane fluidity.
Results show that when FFAs are present the liposome is more fluid.

3.2. RESULTS
3.2.1. Comparison of inhibition by a-tocopherol in micelles and in
liposomes.
Plots of percent inhibition versus concentration of a-tocopherol in systems of
ABAP-initiated oxidation in SDS micelles, and MLV and ULV soy PC liposomes
showed that inhibition in these systems were not similar (Figure 3.3, with
tabulated raw data listed in Table A. 5 of the Appendixes). Inhibition in the SDS
micelles increased to 90 ± 4 % at 10 pM a-T and then decreased gradually.
Inhibition in the MLV system increased to 108 ± 2 % around 25 |iM and then
decreased more dramatically. In the ULV system inhibition increased to 115 ±
15 % at 75 piM before its sharp decrease in inhibition.
Note that in calculating the rates of oxidation, the rate of decomposition of
ABAP (determined in the same system, except with no oxidizable substrate
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Figure 3.3. Inhibition by a-tocopherol in A) SDS micelles , and in
two liposomes models, B) unilamellar vesicles (ULVs) and
multilamellar vesicles (MLVs). Sample A) contained 0.5 M SDS, 46.7 mM
linoleic acid, 88.3 nM DTPA, and 20 mM ABAP. Samples B) and C) contained 20
mg/mL ULV or MLV soy PC, 21.2 mM ABAP, and 88.3 |iM DTPA. Rates of oxidation
were measured using the oxygen electrode.
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present) was subtracted from the rate of oxidation measured by the electrode.
These rates of decomposition are described in chapter 2, Figure 2.2. The
purpose of this calculation was to describe the rate of oxidation as only that
derived from the oxidation of the membrane. The ratio of k,nh to kp was
calculated by dividing the initial concentration of the total oxidizable lipid
substrate by the 50% inhibition concentration. These 50% inhibition
concentrations are shown in Table 3.1.
Based on the percent inhibition versus concentration plots, a-tocopherol was
much less efficient in ULVs than in MLVs or micelles. In fact, the 50% inhibition
concentration calculated for a-tocopherol in ULVs is an order of magnitude
greater than that in micelles (Table 3.1). It is also about five times greater than
that for MLVs.

Table 3.1 Inhibition data for a-tocopherol in various membrane
models.
Membrane Model

50% Inhibition
Concentration
(pM)

Estimated AE
(D-H]5 o/[ArOH]5o)

SDS micelles
MLV Soy PC*
ULV Soy PC'
ULV Soy PCb

2.0 ±0.6
7.2 ±6.2
36.4 ±5.2
60.5 ±14.7

24,000
3500
700
100

a. 20 mg/mL soy PC in phosphate buffer, b. 5 mg/mL soy PC in phosphate buffer.

The 50% inhibition concentration determined for a-tocopherol in SDS
micelles is 2.0 ± 0.6 pM. This is comparable to the value obtained by Strickland,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

57
Pryor, et a l.58 Using the same concentrations of SDS, ABAP, and LH, they
obtained a value of approximately 3 joM.
Antioxidant efficiencies ([LH]50/[ArOH]50 ratios) observed in SDS micelles and
several different liposomal systems, including those from the literature, are given
in Table 3.2. The AE ([LH]50/[ArOH]50 ratio) calculated from data reported in the
literature for inhibition in SDS micelles is an order of magnitude less than the AE
calculated from data presented here for the same system. Interestingly, the AE
calculated for inhibition data presented here for micelles is very similar to the AE
calculated from data reported for homogeneous solution. Another interesting
trend was observed for AE results within the liposomal group. There is
apparently a trend to lower AE as the system changes from MLVs to ULVs
prepared at high phospholipid concentration (20 mg/mL) to ULVs prepared at
low phospholipid concentrations (5 mg/mL).
One discrepancy between the method for calculating AE presented here,
where AE = [LH]so/[ArOH]so, and the traditional calculation using the rate
equation for homogeneous kinetics is apparent for the SDS system (Tables 3.1,
3.2). The antioxidant efficiency calculated using the [LH]so/[ArOH]so ratio for
SDS micelles was 24,000, but using the traditional calculation (AE = IWkp), AE
for micelles was instead 4300.

3.2.2. Effect of free fatty acids on inhibition by a-tocopherol in liposomes.
Concentrations of a-tocopherol required to produce a 50% decrease in the
rate of lipid peroxidation were compared for liposomal systems with and without
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Table 3.2. Antioxidant Efficiencies fora-Tocopherol in Various
Heterogeneous and Homogeneous Systems.______________
System

Estimated AE
([LHWEArOH]*,)

Homogeneous
18:2/t-BuOH /AIBN a

Reference

Niki, et al62
12,400

Micelles
18:2/SDS/ABAP b

24,000

18:2 / SDS/ABAPC

1830

Pryor, Wu, et al“

18:2/SDS/ABAPd

1000

Pryor, Strickland, et al58

18:2/SDS/TBHNe

600

Pryor, Strickland, et al58

Membrane Models
MLVs / ABAPf

3500

ULVs /A B A P /18:09

2600

ULVs / ABAPh

700

ULVs/ABAP'

100

microsomes / ABAPi

109

Krinsky, et a l67

a. Results tabulated from data obtained for 3.99 M AIBN, 0.604 M LH in t-butyl alcohol, and
0.272 -1.71 pM Vitamin E. Rate of oxidation was measured using a pressure transducer, b.
This work. c. Data reported for 0.1 M SDS in 0.3 M phosphate buffer, pH 7.4,2.6 mM LH, and
0.5 M ABAP. Oxidation was measured by following conjugate diene formation, d. Calculated
from data reported from using 0.5 M SDS in 0.5 M phosphate buffer, pH 7.6,46.7 mM 18:2,
4.85-5.24 mM ABAP, and 0.97-1.95 |iM Vitamin E. e. Results obtained using 0.015 M SDS in 50
mM sodium phosphate buffer, pH 7.0,3 mM 18:2, and 0.3 mM di-tert-butyl hyponitrite. Data
were aquired using a Clark-type oxygen electrode, f. Used 20 mg/mL MLV soy PC. g. Used 5
mg/mL ULV soy PC in phosphate buffer with 100 ^M 18:0. h. Same as f., except ULV liposomes
were used. i. Same as g., except no 18:0 was added, j. Results reported using 25 mM ABAP,
0.5 mg/mL microsomes in 0.1 M phosphate buffer, pH 7.5, and 2.5 - 9.0 nmol/mg Vitamin E.
Data were obtained by following malonaldehyde (TBARS) formation. All original work presented
in this paper done using a Clark-type oxygen electrode.
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added free fatty acid (Tables 3.2 and 3.3). Tabulated raw data for this
experiment can be found in the Appendixes, Table A.6. The systems containing
free fatty acid required less a- tocopherol for inhibition than those without FFA.
The model containing 5 mg/mL soy PC and 100 pM oleic acid (Figure 3.4)
showed that at lower concentrations the added free fatty acid increased
inhibition substantially. At a-tocopherol concentrations greater than 150 pM
percent inhibitions calculated with and without FFA were about the same.

Table 3.3. Effect o f Free Fatty Acids on the 50% Inhibition Concentrations
fo r Vitamin E in Various Liposome Systems.________________________
FFA
System
50% Inhibition
Estimated AE
Concentration
([LH]so/[ArOH]5o)
(uM)
18:2
SDS micelles
24,000
1.98 ±0.56
3500
7.15 ±6.15
MLV Soy PCb
18:0
2600
2.50 ±0.18
ULV Soy PCa
700
ULV Soy PCb
36.4 ±5.20
100
60.5 ± 14.7
ULV Soy PCa
-

-

-

a. 5 mg/mL soy PC in phosphate buffer, b. 20 mg/mL soy or egg PC in phosphate buffer.

3.2.3. Effect o f FFA on entrapped volume in ULVs.
The results for the comparison of entrapped volumes for ULVs with and
without stearic acid or a-T are shown in Figure 3.5 (with raw data tabulated and
reported in Table A. 7 of the Appendixes). All concentration ratios of a-T or FFA
to LH were consistent with those present in the oxidation experiments using 5
mg/mL soy PC and 100 pM oleic acid. This figure shows the intensity of an ESR
signal from a membrane permeable nitroxyl radical (TEMPOL) in the presence of
a relatively membrane-impermeable, paramagnetic, spin-broadening Cr (III)
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Figure 3.4. Effect of free fatty acids on inhibition by a-tocopherol in ULVs. Model system
contained 5 mg/mL soy PC ULVs in phosphate buffer, 100 pM DTPA, 5 mM ABAP, and 100 pM oieic acid in some
samples. Rates of oxidation were measured using the oxygen electrode method.
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reported in Table A.7 of the Appendixes). All concentration ratios of a-T or FFA
to LH were consistent with those present in the oxidation experiments using 5
mg/mL soy PC and 100 pM oleic acid. This figure shows the intensity of an ESR
signal from a membrane permeable nitroxyl radical (TEMPOL) in the presence of
a relatively membrane-impermeable, paramagnetic, spin-broadening Cr (III) ion.
Any remaining ESR signal intensity after addition of C r(lll) represents signal
from intravesicular TEMPOL radical. Percent intensity depicted in the graph is
explained in more detail in the section 3.4.2.4 of this chapter. The amount of
remaining signal can further be manipulated to determine the internal or
entrapped volume of the liposome vesicles. As illustrated in the graph (and in
Table 3.4 below), in Tris buffer alone the signal decreases to zero near a Cr (III)
to TEMPOL molar ratio ([Cr]/[T]) of approximately 110. For ULVs, the signal

Table 3.4. Results for measuring the entrapped volume of liposomes
containing g-tocopherol, stearic acid, both or neither._______________
Membrane Model
% Intensity
buffer
ULVs
ULVs, a-T
ULVs, stearic acid
ULVs, g-T, stearic acid

0.0
8.0 ± 0.8
9.8 ±0.8
6.2 ±0.9
8.6 ± 0.6

* Data obtained from minimal signal intensities observed for those data graphed in Figure 3.3.

intensity decreased to about 8.0 ±0.8% at a molar ratio of about 130. In the
presence of FFA, however, the signal intensity decreased to approximately 6.2 ±
0.9%. With a-T present percent intensity was 9.8 ± 0.8% at a molar ratio of 130
and with both FFA and a-T, 8.6 ± 0.6%. Calculations for comparison of the
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3.2.4. Differential Scanning Calorimetry for ULVs with and without FFA and
for MLVs.
DSC was conducted for liposomes containing either a-T or stearic acid or
both. Concentration ratios of a-T or FFA to LH were comparable to those used
in the previous oxidation experiment using 5 mg/mL ULVs and 100 pM oleic
acid. DSC data showing the effect of a-T in liposomes are given in Table 3.5
and Figure 3.6. Note that the addition of a-T to the liposome produces a
broadening of the melting transition and a lower AH. A broadening effect is
normally observed for the introduction of an impurity into the liposom e.122 Here,
Tmis the temperature of transition between the less fluid gel state and the more
fluid liquid crystalline state (Figure 3.7), and AH is the standard enthalpy change
of that transition.122 Calculations for comparison of the means99 using 95%
confidence limits shows that the AH for ULVs and that for ULVs containing 200
liM a-T were statistically different.

DSC data, shown in Table 3.6, Figure 3.8, were then compared for liposomes
with and without stearic acid. Addition of stearic acid to the ULVs also produced
a broadening of the transition. In this case, there was a shift to lower Tm, and a
considerable increase in AH, indicating an increase in the fluidity of the
liposom e.119 Comparison of the means99 at 95% confidence showed that the
observed values for AH in ULVs and in ULVs containing stearic acid were
statistically different. Samples containing both a-T and stearic acid showed a
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Figure 3.6. D ifferential Scanning Calorim etry fo r ULVs Containing
a-Tocopherol. Samples contained 20 mg/mL ULV dioleoyl PC and varying
amounts of a-T and stearic acid.

Table 3.5. D ifferential Scanning Calorim etry fo r ULVs Containing Various
Am ounts o f a-Tocopherol and Stearic Acid.
[Stearate]
Tm (°C)
AH (mJ/mg)
[a-T]
(uM)
(UM)
20.6 ±1.44
-25.2 ±2.01
100
18.7 ±3.37
-24.8 ±1.08
200
17.5 ±3.28
-24.3 ±0.85
200
200
20.7 ±1.37
-24.0 ±0.44
400
200
-23.6 ±0.11
19.1 ±0.77
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"Fluid" Liquid Crystal State

"Solid" Gel State

Figure 3.7. Structures of the two phases for liposomes - gel state and
liquid crystal.

decrease in AH and the Tmshifted back to the transition temperature measured
for ULVs alone.
Finally, DSC data were compared for MLVs and ULVs (Table 3.7, Figure 3.9).
Results show that there is a noticeable increase in AH in MLVs over ULVs.
Interestingly, the transition recorded for MLVs was much more broad than that of
ULVs. In addition, Tmfor MLVs was lower than that of ULVs. Comparison of the
means99 at 95% confidence, however, showed that the results obtained for
MLVs and ULVs were not stastically different.

3.3. DISCUSSION
3.3.1. Comparison of AE for homogeneous and heterogeneous systems of
lipid.
The kinetic analysis used here requires that the majority of peroxyl radicals
come from substrate. Given that the rate of oxidation in the presence of
substrate is at least an order of magnitude greater than the rate of oxidation in
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Figure 3.8. Differential scanning calorimetry for ULVs containing stearic
acid. Samples contained 20 mg/mL ULV dioleoyl PC and varying amounts of
a-T and stearic acid.
Table 3.6. DSC data for ULVs containing varying amounts of stearic acid
and a-T.
[Stearate]
Tm (°C)
AH (mJ/mg)
[a -n
(pM)
(pM)
-

-25.2 ±2.01

20.6 ±1.44

-

200

-24.9 ±0.99

21.4 ±3.47

-

400

-25.5 ±1.30

27.6 ± 3.56

100

400

-24.6 ±1.35

20.6 ±2.59

200

400

-23.6 ±0.11

19.1 ±0.77
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Figure 3.9. D ifferential scanning calorim etry fo r ULVs and MLVs. Samples
contained 20 mg/mL ULV or MLV dioleoyl PC in phosphate buffer.

Table 3.7. D ifferential scanning calorim etry data fo r some membrane
models.
Type o f Liposom e
n
AH
Tm (°C)
(# observations)
(mJ/mg)
ULVs
MLVs

5
3

-25.2 ±2.01
-26.3 ±0.1

19.8 ±1.44
24.6 ±4.7
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its absence (Figures 2.2 and 2.5), the rate of initiation due to peroxyl radicals
derived from the azo initiator is not important. Moreover, the reactivities of
peroxyl radicals derived from the azo initiator and of peroxyl radicals derived
from lipid should be the same.
Antioxidant efficiency was calculated for data reported by Niki, et al62 in their
homogeneous system of lipid (Table 3.2). The calculated value, 12,000, was an
order of magnitude greater than that for data reported for micelles by Strickland,
et al (1000)“ and Pryor, et al (1800).66 By comparison, the AE calculated from
data obtained for microsomes, reported by Krinsky, et al67was only 110, two
orders of magnitude less than in homogeous solution. It appears that as the
model system becomes more membrane-like, a-tocopherol becomes less
efficient in trapping peroxyl radicals. In addition, the AE calculated for ULVs,
700, was less than the AE calculated for MLVs, 3500. This decrease in
efficiency could be due to less fluidity in the liposome. Fluidity in the liposome
determines various physical characteristics of the liposome, including diffusion.
A less fluid liposome might restrict the diffusion of a-T through the membrane.
Interestingly, as discussed in section 3.3.1., the AE calculated here for
inhibition in micelles using the [LH]so/[ArOH]so ratio (24,000) was an order of
magnitude greater than if AE were calculated using the classical rate equation
(4300). The [LH]so/[ArOH]so ratio calculated for data reported by Niki and his
coworkers for inhibited oxidation in homogeneous solution (12,400) was also an
order of magnitude greater than the value for AE that could be calculated using
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the traditional rate equation (5000).62This suggests that the classically accepted
mechanism and kinetics for inhibited autoxidation may not be completely valid.
DSC data obtained for MLVs and ULVs show that MLVs may be more fluid
than ULVs (Figure 3.9, Table 3.7). Once again, a decrease in fluidity and
decrease in diffusion of a-T may account for the smaller AE in ULVs.
Table 3.8 shows lipid-to-a-tocopherol mole ratios in several tissues, which
ranges from 400-5000. This ratio was calculated for work presented here, using
concentrations of a-tocopherol where inhibition was most efficient. In micelles
the ratio is 5800, while in ULVs and MLVs the ratio is 280 and 1000,
respectively. Inhibition data for a-tocopherol in MLVs thus show that atocopherol can only be effective in tissues such as the heart, blood serum and
the brain, but not in the lung or liver. Inhibition data for a-tocopherol in ULVs,
which is the more biologically realistic membrane model, show that a-tocopherol
may not be effective in any of these tissues.

Table 3 .8 . Approxim ate lipid-to-a-tocopherol ratio in selected tissues.
Tissue

mol liDid
mol a-T

Reference

Heart

750

Mitchell, et a l123

Lung

4500

Pacht, et a l124

Liver

2000

Mitchell, et a l123125

Brain and Spinal Cord

700

Muller, et a l126

Blood Serum

450

Sokol, et a l47127
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3.3.2. Dependence of the concentration of a-tocopherol on its inhibition.
Inhibition data for a-T show that in micelles, ULVs, and MLVs inhibition by aT decreases, rather dramatically in the case of ULVs and MLVs, at higher
concentrations of a-T (Figure 3.3). This could be due to competition of the ArO
for LOOH or LH to propagate the chain of free radical reactions. Cillard, et
a l128129 saw similar results for a-tocopherol in their oxidation studies of linoleic
acid emulsions in phosphate buffer. Results such as these were also observed
by Bowry, Ingold, et al. To explain their results, they measured both the rates of
formation of LOOH and the consumption of a-T in low-density lipoprotein (LDL)
at varying concentrations of a-T. At concentrations of 1.8 pM LDL
(approximately 2.5 mM PUFA) and greater than 66 pM a-T (lipid-to-a-T mole
ratio of 37.9), the rate of oxidation was greater than R<* with no antioxidant
present. The lipid-a-T mole ratio for the observation of decreased antioxidant
efficiency of a-T in the MLV and ULV systems presented here were
approximately 120-200 and 120-960, respectively. This decrease in inhibition at
higher concentrations of a-T could possibly be due to prooxidation by atocopherol.

3.3.3. Effect of free fatty acids on membrane fluidity and lipid oxidation.
It has been shown that free fatty acids (FFAs) are released in damaged
tissue. One example is the release of unesterified free fatty acid in the brain
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after trauma. 70,94 It is therefore important to study their effect on the kinetics of
lipid peroxidation and its inhibition. This work clearly shows that the efficiency of
inhibition by a-tocopherol is increased by addition of an essentially nonoxidizable fatty acid such as oleic acid to the liposome system. Oleic acid is not
likely to participate directly in lipid peroxidation (eq 3.1), because as stated in
chapter 1, it is the bis-allylic H atom that is abstracted from the fatty acid. Since
oleic acid has no bis-allylic position, it can be considered to have low
oxidizability. One possible explanation for the increased effectiveness of the
antioxidant in the presence of oleic acid is that FFAs serve to increase fluidity
and diffusion across the membrane.
In order to explain this theory, an understanding of the physical
characteristics of membranes is first necessary. First of all, membrane fluidity is
a thermodynamic description of the membrane’s phase behavior. Remember
that membranes can exist in either an ordered gel phase or a more fluid liquid
crystalline phase. In the gel phase, the fatty acyl chains are more tightly packed
than in the liquid crystal.55 For this reason, a decrease in fluidity in the
membrane generally indicates an increase in order, a physical description of the
lipid chain packing.55 It has been shown that small ions or molecules permeate
the membrane more readily in the membrane’s liquid crystalline phase.55
Increases in membrane permeability thus suggest increases in fluidity. Because
increases in fluidity and decreases :n order imply less lipid packing, greater
diffusion of membrane proteins usually also coincide with increases in fluidity.
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Studies have shown that FFA does appreciably increase membrane
permeability, calcium transport, and.prote»n diffusion. ®-72M

3.3.4. Effect of FFA on entrapped volume.
Measurements for the entrapped volume of the liposome vesicle show that
there is no significant change in entrapped volume or size of the liposome in the
presence of either a-T, stearic acid, or both. This means that the increase in
inhibition of oxidation by a-T was not due to a disruption of the integrity of the
liposomes. The presence of a-T did cause a slight increase in the entrapped
volume of ULVs, thus suggesting a small increase in chain packing in the
liposome. It has been shown that an increase in lipid chain order actually
causes the bilayer to become thinner.55 This could then result in an increase in
the entrapped volume of the vesicle.55 The increase in chain packing could
result from both the hydrogen-bonding of a-T to the polar head groups on the
lipid and the hyrodrophobic interactions between a -T s hydrocarbon tail and the
phospholipid side chain (Figure 3.10).

3.3.5. Effect of FFAs and a-T on Tm.
Differential scanning calorimetry data were obtained for ULVs with and
without a-tocopherol and stearic acid. It has been shown that Tm is dependent
on the intermolecular attractive forces between the phospholipid
headgroups.122,130An increase in these attractions produces more stability in the
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liposome, thus less fluidity, and the observed Tmincreases. On the other hand,
AH depends on the distance between the hydrocarbon chains. 122,130An increase
in the van der Waals attractions between these hydrocarbons produces more
stability in the liposome, thus less fluidity, and there is a decrease in the
observed AH. Though there was no obvious change in Tm, there was a slight
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Figure 3.10. Disruption of both hydrophobic interactions and hydrogen
bonding between a-T and lipid by free fatty acid.
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decrease in AH in the presence of a-T, suggesting a-T might cause the liposome
to be more stable or less fluid! This had been previously observed by Suzuki
and coworkers when they measured molecular motion of a spin label in
liposom es.131. They showed that the addition of a-T elicited less molecular
motion of a spin label, thus showing the liposome containing a-T was more
ordered.
Stearic acid, however, produced an increase in AH for the liposome’s gel to
liquid crystal transition, suggesting it produces more fluidity in the membrane.
Mabrey and Sturtevant, on the other hand, showed by DSC that addition of
saturated fatty acids to the membrane model increased order.120 They argued
that the introduction of the FFA into the bilayer decreases crowding in the polar
head groups by increasing the distance between them. This, in turn, increases
stability or order in the membrane. The difference between their data and the
data presented in this paper is that they used a 2:1 lipid to FFA mole ratio and
the mole ratio here was at least a 65:1 molar ratio. At the concentrations they
used, the stearic acid - fatty acyl van der Waals attractions become more
important than the fatty acyl - fatty acyl attractions. In the case of the data
presented here, the stearic acid served merely as an impurity that produced less
order in the membrane. Results similar to those shown here were also reported
by Schaeffer and Zadunaisky when they measured diffusion of
immunofluorescently-labeled proteins in plasma membranes treated with low
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concentration of fatty acids.73They observed greater greater diffusion of the
labeled protein in the presence of FFA, and thus, less order.
The resuits presented in this research indicate that there is an increase in the
fluidity of the membrane model when FFA are present. The increase in AE for a T in the presence of FFA may therefore be due to an increase in fluidity in the
liposome. It is possible that in ULVs containing a-T, there are strong
intermolecular forces, as mentioned earlier, that produce tighter packing in the
liposome, and thus, less fluidity and more order (Figure 3.10). When the FFA
are introduced, there are stronger interactions between the FFA and a-T than
between a-T and the phospholipid. This disrupts the packing of the
phospholipid and results in less order or more fluidity in the membrane. It is
therefore possible that there is an increase in the diffusion of a-T through the
more fluid membrane when FFA are present. A more mobile a-T may be thus
more effective at trapping free radicals in damaged tissue than in normal tissue
in vivo.
This paper shows that the choice of membrane model used to evaluate the
effectiveness of an antioxidant is highly important. While biomembranes contain
many components such as proteins that make interpretation of various aspects
of lipid peroxidation difficult, membrane models provide a simple and
uncomplicated picture of the chemistry within lipid membranes. The data clearly
show that the effectiveness of a-tocopherol decreases dramatically as the
membrane models become more rigid and, hence, more biologically relevant.
The effectiveness of a-tocopherol in vivo may also be questionable, especially at
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higher concentrations, where prooxidation may take place. The data do suggest
that a-T may be more effective in damaged tissue, where FFAs are present.

3.4. EXPERIMENTAL
3.4.1. Materials.
Linoleic add (cis,cis-9,12, octadecadienoic acid), Oleic acid (c/s-9octadecenoic acid), diethylenetriaminepenta-acetic acid (DTPA), L-aphosphatidylcholine from frozen egg yolk (egg PC), type V-E and l-aphosphatidylcholine from soybean (soy PC), type lil-S were obtained from Sigma
Chemical Co. A crude source of soy phosphatidylcholine was obtained
commercially in the form of L-a-lecithin capsules and was purified by flash
column chromatography using silica gel (Chapter 2, section 2.4.1.1.). Granular
2,2' azobis-2-amidinopropane (ABAP), type V-50, was obtained from Wako Pure
Chemical Industries, Ltd. D,L-a-tocopherol was obtained from Hoffman-La
Roche, Inc. TEMPOL (4-hydroxy-2,2,6,6-tetramethyl-piperidinyl-1-oxy) was a
gift from Exxon Chemicals (8320 Stedman, Houston, TX). Potassium
tris(oxalato)chromate(lll) trihydrate was prepared as described by Bergmann, et
a l.115 Dioleoyl phosphatidylcholine (1,2-dioleoyl-sn-glycero-3-phosphocholine)
was purchased from Avanti Polar Lipids (Alabaster, AL). These and all other
incidental chemicals and solvents were of high purity and were used as
received.
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3.4.2. Methods.
3.4.2.1. Determination of 50% inhibition concentration of a-tocopherol for
SDS micelles using ABAP initiation.
A 15 mM solution of sodium dodecyl sulfate (SDS) was prepared in 50 mM
sodium phosphate buffer (pH 7.4). To 3 mL of this solution, linoleic acid, DTPA,
and ABAP were added, so that their final concentrations were 46.7 mM, 88.3
IiM, and 20 mM, respectively. The decrease in oxygen concentration was
followed using a Clark-type oxygen electrode. Plots of oxygen concentration as
a function of time were constructed using computer software interfaced to the
oxygen electrode via a 12 bit A/D converter. Increasing amounts of a-tocopherol
in ethanol were added a few pL at a time. After each addition, the decrease in
oxygen concentration was measured over time.

3.4.2.2. Measurement of the inhibition of oxidation in MLVs and ULVs.
Multilamellar and unilamellar vesicles were prepared by first evaporating
under vacuum a 20 mg/mL purified soy phosphatidylcholine (PC) solution in
chloroform and containing varying amounts of a-tocopherol. The PC was
resuspended in 50 mM phosphate buffer, pH 7.4, so that its final concentration
was again 20 mg/mL. MLVs and ULVs were then formed using the methods
described for each in chapter 2, section 2.4.2.1. To 2.7 mL of either MLVs or
ULVs in buffer, 10 pL of a 25 mM solution of DTPA in water and 120 pL of a 0.5
M solution of ABAP in water were added, so that the final concentrations were
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88.3 fiM DTPA and 21.2 mM ABAP. After equilibration, oxygen concentration
was monitored as described previously.

3.4.2.3. Measurement of the effect of free fatty acid on inhibition by
a-tocopherol.
A stock solution of soy PC in chloroform containing varying amounts of atocopherol was evaporated to a film under vacuum. To demonstrate the effect
of free fatty acids on antioxidant efficiency, this mixture for rotor evaporation also
included oleic acid for some experiments. The mixture was resuspended in 3 mL
of 50 mM high ionic strength phosphate buffer (containing 100 |iM DTPA), pH
7.4, so that the final concentrations were 5 mg/mL PC, 0-200 pM a-tocopherol,
and 100 pM oleic acid in some samples. Ionic strength buffer is often used to
prevent liposome aggregation in solution.55Though high ionic strength
phosphate buffer was used in this experiment, rates of oxidation in normal
phosphate buffer were shown to be very similar. ULVs were then prepared
using the method described in chapter 2, section 2.4.2.1. A 2.7 mL aliquot of the
resulting ULV solution was placed in the oxygen electrode cell, and 75 (iL of a
0.5 M ABAP solution in water was added, so that its final concentration was 13.5
mM in the phosphate buffer. The rate of decrease in oxygen concentration was
measured by oxygen electrode method. Plots of percent inhibition of the rate of
oxidation versus concentration of a-tocopherol were constructed for data
obtained with and without added oleic acid.
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3.4.2.4. Measurement of the entrapped volume in ULVs.
Entrapped volumes of the liposomes were determined according to the
method described by Vistnes and Puskin.11* Liposomes containing the
membrane-permeable spin label TEMPOL132 and with and without added FFA
were extruded as described previously. Tris(oxalato)chromate(lll), a relatively
impermeable paramagnetic ion,132was then added in increasing concentrations
as a spin label broadening agent. Because the solvent in these samples was
water, special steps were taken in the aquisition of ESR spectra. Water is
known to absorb microwave energy very strongly.133As a result, the added
energy causes a large decrease in relaxation time and the signal is quenched.133
To reduce signal quenching due to water, each sample was placed in a capillary
tube under vacuum, and the capillary tube, inside an ESR tube. The ESR
spectrum for the spin label was obtained using an X-band Micro-Now Instrument
Co. 8300A ESR spectrometer with a center field of 341 mT. Spectral parameters
included a 5G modulation amplitude, a 100 G field width, a 100 s scan time, and
a 0.1 s time constant. ESR spectra were then obtained for each of the samples.
Signal intensity was determined by measuring peak heights using computer
software. Percent intensity was calculated for each sample by dividing the
signal intensity for each sample containing chromium oxalate by the intensity of
the control sample containing no added chromium oxalate (eq 3.8). The percent
intensity of the signals were plotted versus the mole ratio of C r(lll) to moles of
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%Intensity =

ln t(TemPoi+Criii) X1Q(J
lnt(Tempol)

(3-8)

TEMPOL. Note that the liposomes were prepared in 50 mM Tris buffer, pH 7.4.
Though deionized water may be used, phosphate buffer may not, since it
appears to coordinates to the chromium oxalate and prevents its action as a spin
broadening agent. Also, NaCI was added to each sample in a manner to
maintain ionic strength throughout. Maintaining ionic strength is important in
preventing liposome aggregation.55

3.4.2.5. Measurement of Tmusing Differential Scanning Calorimetry.
Chloroform solutions of soy PC (purified as described in chapter 2, section
2.4.1.1) containing varying amounts of stearic acid and a-T were evaporated to
a film using rotory evaporation. The samples were redissolved in 0.5 mL 50 mM
Tris buffer, pH 7.4, such that the final concentration of PC was 20 mg/mL.
Samples were then either sonicated to produce MLVs or extruded to produce
ULVs (both prepared as described in chapter 2, section 2.4.2.1). Samples for
DSC were placed in aluminum hermetic pans and DSC data were obtained using
a Seiko DSC 220C calorimeter, operating at a scan rate of 1°C/min.
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CHAPTER 4: EVALUATION AND pH DEPENDENCE OF
INHIBITION BY THE 21-AMINOSTEROID U74006
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4.1. INTRODUCTION
The goal of this research was to compare the antioxidant efficiency of
U74006 with that of a-tocopherol in systems of noniron-dependent lipid
peroxidation in ULV phosphatidylcholine liposomes. Furthermore, we compared
the antioxidant efficiency of U74006 and a similar 21-aminosteroid, U74389
(Figure 4.1), with that of the amine functionality alone, designated here as MACacetamide.
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Figure 4.1. Structures for 21 -aminosteroids used in this study.

Finally, we studied the pH dependence of the antioxidant efficiency of
U74006. This aspect becomes increasingly important in damaged tissue, where
the pH is known to be fairly acidic.25 We find that the antioxidant is greatly
affected by pH and is much less efficient below pH 7.
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4.2. RESULTS
4.2.1. Comparison of the inhibitions of the 2 1 -aminosteroids with
a-tocopherol in ULVs.
Inhibition of oxidation in ULVs by MAC-acetamide, U74006, and U74389 are
compared in Figure 4.2 (with the raw data and their error analysis in the
appendixes, Table A.8). Percent inhibition here represents the decrease in the
rate of oxidation (in the presence of antioxidant) divided by the uninhibited rate
of oxidation (with no antioxidant present). All three antioxidants, U74006,
U74389, and MAC-acetamide, inhibited oxidation. None of the 21-aminosteroids
tested, however, demonstrated anything close to 100% inhibition. Maximum
inhibition was approximately 75% for U74389, 60% for U74006. and 55% for the
MAC - acetamide.
In order to compare inhibition by a - tocopherol with that by the
21-aminosteroids, 50% inhibition concentrations were calculated. The 50%
inhibition concentration represents the concentration of antioxidant required to
produce a 50% decrease in the rate of uninhibited oxidation. Thus, a smaller
50% inhibition concentration corresponds to a more effective antioxidant. For a
more detailed discussion of 50% inhibition concentrations and their implications,
see chapter 3, section 3.1. As shown in Table 4.1, the 50% inhibition
concentration for a-tocopherol, 39 pM, was less than any of the other
antioxidants studied. The 50% inhibition concentration measured for U74389
and U74006 were 104 and 205 pM, respectively. These values were greater
than that of a-tocopherol by a factor of 2 - 3. Finally, the 50% inhibition
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Figure 4.2. Comparison of percent inhibition measurements for A) MAC-acetamide B) U74389,
and C) U74006. Systems contained 21.2 mM ABAP and 88.3 pM DTPA in 20 mg/mL ULV soy PC. Rates of oxidation
were measured by oxygen consumption method using an oxygen electrode.
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concentration calculated for MAC-acetamide was 206 uM, greater than that of atoccphero! by a factor of 5. In this liposome system, cc-tocophercl was thus a
much more effective antioxidant than either of the 21-aminosteroids or
MAC-acetamide.

Table 4.1. Comparison of Inhibition by 21-Aminosteroids and aTocopherol in ULV Liposomes.
Antioxidant

50% Inhibition Concentration
( mM)

MAC-acetamide
U74389
U74006
a-Tocopherol

206 ± 38
104 + 7
205 ± 81
36 ± 5

Inhibition was measured in 20 mg/mL ULV soy PC in 50 mM phosphate buffer, pH 7.4, and
containing 21.2 mM ABAP and 88.3pM DTPA.

4.2.2. Effect of pH on inhibition by U74006.
As shown in Figure 4.3, the antioxidant effectiveness of U74006 decreased
dramatically when the pH changed from 7.0 to 6.5. In particular, the 50%
inhibition concentration increased from 100pM at pH 7.0 to 200pM at pH 6.5.
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This means that the antioxidant was only half as effective at pH 6.5 as compared
to pH 7.0.

4.3. DISCUSSION
Results presented here show that U74389 and U74006 exhibit about the
same antioxidant effectiveness in ABAP-initiated ULV liposomes. This is shown
in Figure 4.2 and Table 4.1. Furthermore, U74389 demonstrated the same or
perhaps a greater antioxidant effectiveness than MAC-acetamide. If indeed the
21-aminosteroids are better antioxidants than MAC-acetamide, this could be due
to the added benefit of the steroid functionality on the U74389. Steroids such as
cholesterol have been shown to be membrane stabilizers, in that they bring
about more order in the membrane. 134,135Creating a more rigid bilayer may
decrease the number of free radicals capable of diffusing through to the
hydrophobic region of the membrane to initiate lipid oxidation. A second
explanation could be that addition of the steroid affords the antioxidant more
favorable partitioning into the hydrophobic lipid bilayer where lipid peroxyl
radicals reside.
In comparison to a-tocopherol, U74006 and U74389 are not as effective in
inhibiting oxidation. In ULV liposomes, a-tocopherol proved to be more effective
than MAC-acetamide and the 21 -aminosteroids by factors of 3-5. Neither the
21-aminosteroids nor MAC-acetamide, however, was ever completely effective in
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the liposomes, in that percent inhibition never reached 100% in either case.
This means that the antioxidants do not shut down autoxidation in this liposomal
membrane model.
Finally, the efficiency of U74006 appears to have associated with it a very
large pH dependence. In fact, the antioxidant efficiency of U74006 decreases
by half between pH 6.5 and pH 7.0. This means that in oxidatively damaged
tissues where the pH is shown to be somewhat acidic,25 U74006 may be even
less effective at terminating lipid peroxyl radicals.
This research thus indicates that while U74006 and U74389 do exhibit
antioxidant activity, they are not as effective as a-tocopherol in the liposome
model. Furthermore, in oxidatively damaged tissue in vivo where the pH is
reduced, the 21-aminosteroids might actually be very inefficient antioxidants. It
is possible that the observed decrease in antioxidant effectiveness at lower pH is
due to a change in the geometry of the molecule when the antioxidant becomes
protonated. The protonated molecule may assume a geometry that decreases
its ability to insert into the membrane to both trap free radicals and to increase
membrane stability.
Though the 21-aminosteroids were shown here to be somewhat ineffective,
they have been shown to be effective clinically. It is therefore possible that they
inhibit lipid peroxidation by some other non-chemical mechanism.
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4.4. EXPERIMENTAL
4.4.1. Materials:
Soy phosphatidylcholine was purified from lecithin tablets using flash-column
chromatography (described in Chapter 2, section 2.4.1.1). MAC-acetamide, or
U98982 (4-(2,6-di-1 -pyrrolidinyl-4-pyrimidinyl)-1 -piperazinyl acetate), and the
21 -aminosteroids U74389 (21 -[4-(2,6-di-1 -pyrrolidinyl-4-pyrimidinyl)-1 piperazinyl]-pregna-1,4,9(11 )triene-3,20-dione) and U74006 (21-£4-(2,6-di-1 pyrrolidinyl-2-pyrimidinyl)-1 -piperazinyl]-16.alpha.)-pregna-1,4,9(11 )-triene-3,20dione) were gifts from Pharmacia Upjohn, Inc. Note that U74389 and U74006
were the organic soluble versions of U74389G and U74006F and were used
here for experimental convenience. Diethylenetriamine penta-acetic acid
(DTPA) was purchased from Sigma Chemical Co. Granular 2,2' azobis-2amidinopropane (ABAP), type V-50, was obtained from Wako Pure Chemical
Industries, Ltd. These and all other incidental chemicals used were of high
purity and were used as obtained.

4.4.2. Methods:
4.4.2.1. Measurement of the inhibition by U74389, U74006, and MAC acetamide in ULV soy PC liposomes.
ULVs containing varying concentrations of U74006, U74389, or MACacetamide were prepared by first rotory evaporating together a solution of soy
PC in chloroform and various amounts of a chloroform stock solution of the
antioxidant to be studied. A 20 mg/mL soy PC solution was then formed by
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redissolving the lipid in the appropriate amount of 50 mM phosphate buffer, pH
7.4. ULVs were then prepared using the method described in chapter 2, section
2.4.2.1. Diethyienetriamine penta-acetic acid (DTPA), an iron chelator, and 2,2'azobis-2-amidinopropane (ABAP), an azo initiator, were then added so that the
final solution contained 88.3 pM DTPA and 22 mM ABAP. The rate of oxidation
was followed by measuring the decrease in oxygen concentration versus time
using a Clark-type oxygen electrode interfaced via a 12 bit A/D converter to
computer software.

4.4.2.2. Evaluation of the effect of pH on inhibition by U74006.
The effect of pH was determined in samples of 20 mg/mL ULV soy PC
liposomes containing U74006, prepared as described in chapter 2, section
2.4.2.1. To evaluate the AE of the 21-aminosteroids as a function of pH, the
samples were extruded in 50 mM phosphate buffer of varying pH. Oxidation
was initiated using ABAP and its rate was followed by oxygen electrode method.
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Important to the study of lipid peroxidation is the use of membrane models.
Simple and uncomplicated, biologically realistic membrane models allow for a
quick and easy elucidation of many aspects of both lipid peroxidation and its
inhibition.90The primary goal of this research was to explore lipid peroxidation
and its inhibition in membrane models. To accomplish this objective, three sets
of experiments were performed. First of all, the kinetics of lipid peroxidation in
two liposome models, unilamellar vesicles (ULVs) and multilamellar vesicles
(MLVs), were studied. The results of these experiments were presented in
chapter 2. Secondly, the inhibition of lipid peroxidation by a-tocopherol in MLVs
and ULVs was investigated. Furthermore, the effects of membrane structure and
free fatty acids on this inhibition were explored. The discussion of these
experiments was covered in chapter 3. Finally, the inhibition of lipid peroxidation
in liposomes by a group of synthetic antioxidants called 21-aminosteroids as
compared to inhibition by a-tocopherol was presented in chapter 4.

5.1. Kinetics of lipid peroxidation in membrane models.
Data resulting from this research as well as that found in the literature show
that the kinetics of homogeneous solution and of micelles may not be the same
as those of the more biologically realistic membrane models studied here liposomes (Table 5.1 j.58-63*5. it was observed that the kinetics of autoxidation
were different in the large ULVs and in the MLVs studied here.
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Table 5.1. Comparison of orders obtained for measuring the kinetics of
lipid peroxidation in membrane models.__________________________
Membrane Model
[ABAP]
[LH]
[OJ
Homogeneous
SDS micelles
MLVs
ULVs

0.50a
1.00
0b
0.50*
1.00
0b
1.37 ± 0.10
0.76 ±0.10
0.09 ±0.05
1.35 ±0.18_______0.17 ±0.10_______ 0 05 ±0.01

a. Data reported by Pryor, et a l.30 b. As reported by Burton, Ingold, and others.1JO

One explanation for the kinetic differences between all of the model systems
compared here may be the differences in O2 concentrations in the membrane
models. While autoxidation was shown to be virtually independent of [0 2] in
solution and in micelles, Barclay and Ingold noticed that the rate law for
autoxidation in liposomes is slightly affected by the oxygen partial pressure.100
They argue that as the oxygen partial pressure decreases, chain transfer may
begin to occur by a cross termination mechanism (eq 5.2), as opposed to
termination by coupling of two lipid peroxyl radicals (eq 5.1).

2LOO' ----------- ► non-radical products

(5

1

)

LOO* + L * ----------- ► non-radical products

^5 2

)

Cross terminations such as that in eq 5.2 in addition to the reaction in eq 5.3
might become increasingly important in oxygen-deprived membranes, where the
ratio of L’ to LOO’ increases.100There may likewise be a dependence of
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autoxidation on [O 2 ] in the membrane models studied here (Table 5.1).
Statistically, the orders in 0 2 in both MLVs and ULVs are different from zero.

2L-

----------- ► non-radical products

(5 3

)

While Barclay's group observed classical kinetics in their membrane models
of small ULVs and MLVs, they did note that ULVs were more susceptible to
oxidation than M LVs.102They rationalized this based on lipid chain packing in
the two models. They argue that the higher oxidative susceptibility of ULVs is
due to higher local concentrations of oxidizable methylene groups. This would
then result in higher rates of propagation.
The large order with respect to Ri observed in both MLVs and ULVs (Table
5.1) could be due to induced decomposition.137With the occurrence of induced
decomposition the order in Rj has been shown to be greater than 3/2. 137
Induced decomposition is a bimolecular process in which free radicals attack
a non-radical compound and cause it to decompose.137One plausible
mechanism for induced decomposition in the MLVs and ULVs studied here is
given in eq 5.4. In this mechanism, LOO' attacks the peroxidic (O-O) bond of
the non-radical LOOH. It is possible that as lipid chains become more restricted,
the probability of a lipid peroxyl radical encountering another of its kind for
termination is much smaller.
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LOO- + LOOH

^

(LOOOH) + LO
I

► LO- + -OOH

Overall:
LOO- + LOOH ---------- ►

2LO- + -OOH

(5 . 1 )

Overall, ULVs appear to be more kinetically different from the classical rate
law than MLVs. This may be because MLVs are more fluid and ULVs, more
rigid. It is thus reasonable to assume that ULVs are both the most biologically
and kinetically realistic membrane models of the model systems compared here.

5.2. Inhibition of lipid peroxidation by a-tocopherol.
Fortunately, the body possesses several natural antioxidants to prevent
against oxidative damage.7 These include a-tocopherol (Vitamin E), p-carotene,
ascorbic acid, and enzymes such as superoxide dismutase and catalase, to
name a fe w .7 Recently, a pharmaceutical movement toward developing
synthetic antioxidant drugs has emerged. 722-“ 91 The use of realistic membrane
models is important to the study of antioxidants, as they provide a route to
simple and fast comparisons of the effectiveness of antioxidants. The results
presented in this dissertation suggest that the choice of membrane model is
critical, as the kinetics of inhibition in each may be quite different. In this set of
experiments, the antioxidant efficiency of a-T was therefore determined for
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oxidation in SDS micelles, MLVs and ULVs. These efficiencies were compared
with others reported in the literature for the same or different systems.
The antioxidant efficiency of a-T was measured here by comparing 50%
inhibition concentrations. This value was used for comparison because it can be
calculated without first determining the rate equation for inhibited oxidation.
There was a dramatic decrease in the antioxidant efficiency of a-T from micelles
to liposomes.58®6667 Comparing these results with others in literature,
antioxidant efficiency decreases from homogeneous solution to micelles, and
from micelles to microsomes and liposomes. 58-6266-68 Perhaps as the model
becomes more rigid, it becomes increasingly difficult for a-T to encounter and
trap peroxyl radicals.
Oxidation data show that a-T is more efficient in MLVs than in ULVs. DSC
data suggest that MLVs may be more fluid than ULVs. MLVs should thus allow
a-T to diffuse more readily. An interesting result observed from DSC data was

the decrease in the fluidity of ULVs in the presence of a-T. This may be
evidence that in liposome models a -T is more restricted and less efficient at
encountering and trapping free radicals than it is in homogeneous solution.
The inhibition data for a-tocopherol do suggest that a-T may not be very
efficient in real tissues. In liposomes, especially in ULVs, a-T was only
completely efficient at concentrations greater than that that exists is real tissues.
It is difficult to predict what the efficiency of a-T may be in real tissues, though,
since real membranes contains a large amount of protein, and these proteins
have been shown to participate in autoxidation.138
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Interestingly, at high concentrations of a-T, antioxidant efficiency decreased
substantially. This was also observed by several other groups for both a-T and
Trolox. 128>129'139-141 Bowry and Ingold have reasoned that this is probably due to
chain propagation via the tocopheroxyl (phenoxyl) radical.139-140142 They further
argue, perhaps incorrectly, that at high concentrations, the persistent
tocopheroxyl (phenoxyl) radical located in lipophilic region rarely encounters free
radicals (LOO‘) residing in aqueous solution. This assumption is probably
based on the “Floating” Peroxyl Radical Hypothesis.101,143 It has been theorized
that once formed, the peroxyl radical, shown to have a very high dielectric
constant, “floats" toward the aqueous layer to hydrogen bond with w ater.101,143
The phenoxyl radical generated from a-T then instead terminates by abstracting
a hydrogen atom from a molecule of lipid in close proximity to produce a chainpropagating lipid alkyl radical.139The problem with the “Floating" Peroxyl
Radical Hypothesis is that it suggests a decrease in order or increase in fluidity
during autoxidation. Moderate levels of lipid peroxidation, however, were shown
to increase order and decrease membrane permeability and fluidity in
microsomes.144
Perhaps a better explanation comes from analysis of oxidation products for aT, reported by Leibler, et a l.48 Leibler observed an a-T oxidation product that
could be the result of a prooxidation reaction (Figure 5.3). In this mechanism the
phenoxyl radical produced by H-atom abstraction by LOO', now of high
concentration, reacts with LOO* to form an epoxy alkyl radical and L 0 ‘ by p-
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scission (Figure 5.3). The epoxy alkyl radical then reacts with O2 to produce a
peroxyl radical. This a-tocopherol-derived peroxyl radical can then abstract a Hatom from another molecule of lipid to terminate itself and produce a chain
propagating lipid alkyl radical. This is an important consequence, because in
this case a-T has terminated only one LOO' and has generated one LO' and one
L\

LOO*

to .-* '
H

Figure 5.3. Oxidation products of a-T that may suggest mechanism for
prooxidation.
It was observed that a-T was highly effective at low concentrations in the
presence of free fatty acids. This could infer that a-T may be more effective in
damaged tissue, where FFA have been shown to be released. 70,94This increase
in antioxidant efficiency may be due to an increase in fluidity in the membrane
when FFA are present. A similar increase in fluidity in the membrane in the
presence of FFA was observed by. Schaeffer and Zadunaisky, measuring
diffusion of immunofluorescently-labeled proteins in plasma membranes.73 This
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suggests that lipid packing is smaller in the presence of FFA. DSC data
presented here likewise show that FFAs produce more fluidity in the liposome.
A more fluid lipid bilayer may allow for greater diffusion of a-T through the
membrane to terminate lipid peroxyl radicals.

5.3. Inhibition of oxidation by 21-aminosteroids.
The recent trend toward developing synthetic antioxidant drugs seems
promising.7 Pharmacia & Upjohn, Inc., have developed an antioxidant, the 21aminosteroid U74006, it hopes will prove effective against CNS trauma and
prevent tissue damage following stroke.145
Antioxidant efficiencies of a-T, U74006, U74389, and MAC-acetamide,the
acetylated pyrimidine with no attached steroid, were compared in ULVs. It was
observed that none of the 21 -aminosteroids studied were as effective as a-T. In
addition, none of the 21-aminosteroids studied were completely efficient, in that
percent inhibition never reached 100%. Of the 21-aminosteroids, U74389 was
more effective than either U74006 or MAC-acetamide by a factor of 2.
The antioxidant efficiency of U74006 was shown here to decrease by half
from pH 7.0 to pH 6.5. This could be due to a change in geometry in the
molecule after protonation. The protonated molecule may assume a “bent”
orientation that penetrates the liposome only minimally. It is thus possible that
U74006 may be ineffective in already damaged tissues, which are typically of
lower pH .25This finding, in conjunction with its low efficiency in comparison to a-
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T, leave doubt as to the effectiveness of this drug as an antioxidant, effective by
only a chemical mechanism. Since it has been shown effective in vivo in
preventing reperfusion injury,92146 it is possible that it inhibits lipid peroxidation
by some other mechanism. Perhaps it inhibits one of the biological processes
involved in ischemia.

5.4. Summary.
This dissertation thus demonstrates that the choice of membrane model for
evaluating lipid peroxidation is critical, as the kinetics of each are quite different.
Comparing liposomes and other membrane models, it is shown here that a-T
appears effective in homogeneous solution, micelles, and liposomes modeling
damaged membranes. Its antioxidant efficiency, however, is much lower in
liposome models for undamaged membranes. Finally, while the effort toward
developing synthetic antioxidant CNS drugs is promising, more work may need
to be done to find an antioxidant that is at least as effective as a-T and whose
activity has little or no pH dependence.
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Table A.1. Tabulated results for the effect of media on the rate of
decomposition of ABAP, shown in Figure 2.2.___________
Media
Rate ± o
n
[ABAP]
{# observations)
(pM/sec)
(mM)
Phosphate
buffer3

SDS micelles

MLV
hydrogenated
PCc

0.0
3.3
5.0
6.7
10.0
12.5
25.0
30.0
0.0
0.8
1.7
2.5
3.3
4.2
5.0
6.7
8.3

0.0
3.6
5.2
7.0
10.5
13.9
15.3
17.2
20.2
20.6
23.8
25.0
27.2
29.7
32.0

2
1

1
1
1

4
1
2
2
1
2
1
2
1

2
1
1

2
1
1

2
2
2
1

2
1
2
2
1
1
1

1

0.0016 + 0.0000
0.0036
0.0079
0.0061
0.0080
0.0114 ±0.0008
0.0181
0.0207 ±0.0036
0.0011 ± 0.0002
0.0015
0.0014 ±0.0002
0.0027
0.0024 ±0.0012
0.0023
0.0036 ± 0.0008
0.0045
0.0048

0.0004 ± 0.0002
0.0005
0.0035
0.0044 ± 0.0051
0.0046 ±0.0018
0.0060 ± 0.0007
0.0072
0.0074 ±0.0014
0.0107
0.0082 ± 0.0028
0.0097 ± 0.0048
0.0116
0.0202
0.0104
0.0176
(table con’d)
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ULV hydrogenated
pCd

0.0
4.1
5.5
8.8
10.9
12.2
16.1
17.2
20.0
21.3
23.8
25.4
27.6
30.2
31.3

3
1
1
1
1
1
1
1
1
1
1
1
1
1
1

0.0021 ±0.0012
0.0022
0.0019
0.0063
0.0040
0.0077
0.0120
0.0087
0.0143
0.0097
0.0157
0.0120
0.0127
0.0146
0.0150

Samples contained increasing concentrations of ABAP in the following systems: a. 50 mM
phosphate, pH 7.4,83.3 pM DTPA b. 0.5 M SDS micelles in buffer, 83.3 pM DTPA c,d. 20
mg/mL MLV or ULV hydrogenated egg PC in buffer, 83.3 pM DTPA. Data were obtained using
the oxygen electrode method.

Table A.2. Tabulated data obtained fo r measuring the order in ABAP,
shown in Figure 2.4.
log[ABAP]
log[Rate]
Membrane Model
n
(# observations)
-2.60
SDS micelles
2
-7.36 ± 0.01
-2.30
2
-7.21 ±0.00
-2.13
2
-7.12 ± 0.05
-2.00
2
-7.06 ± 0.04
-1.90
2
-7.02 ±0.03
-1.82
2
-6.98 ± 0.03
-2.60
-8.47
1
MLVs
-2.30
1
-7.88
-2.13
1
-7.81
-2.00
1
-7.61
-1.90
1
-7.40
-1.82
1
-7.25
-2.60
1
-8.37
ULVs
-2.30
2
-8.629 ± 0.45
-2.13
2
-7.99 ±0.25
-2.00
1
-7.69
-1.90
2
-7.44 ± 0.16
-1.82
1
-7.40
-1.76
-7.33
1
Samples contained varying concentrations of ABAP in a. 0.5 M SDS in buffer, 46.7 mM linoleic
acid, 83.3 pM DTPA, b,c. 20 mg/mL MLV or ULV soy PC in buffer, 83.3 pM DTPA. Data were
obtained using the oxygen electrode method.
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Table A.3. Tabulated data fo r measuring the order in LH, shown in Figure
2.5._____________________________________________________________
log[LH ]
log[Rate] ± 0
Membrane Model
n
(# observations)
-3.00
-7.46
1
MLVs
-2.60
1
-7.22
-2.30
2
-7.17 ±0.07
-2.13
-7.02
1
-2.00
2
-7.14 ±0.08
-1.90
1
-7.08
-1.82
2
-6.93 ± 0.26
-1 .7 6
1
-7.01
-1.70
2
-6.88 ±0.28
-2.60
1
-7.24
ULVs
-2.30
1
-7.32
-2.00
-7.21
1
-1.90
-7.09
1
-1.82
-7.05
1
-1.76
2
-7.13 ±0.27
-1.70
3
-7.14 ±0.03
Samples contained varying concentrations of either MLV or ULV soy PC diluted with
hydrogenated egg PC to control LH concentration. Samples also contained 83.3 pM DTPA and
21.2 mM ABAP. Data were obtained using the oxygen electrode method.

Table A.4. Tabulated data fo r measuring dependence o f [O 2 ] on the rate o f
oxidation in MLVs and ULVs, shown in Figure 2.6.______________________
Membrane Model
[OJ
Rox ± a
(pM)
(# observations)
(pM/sec)
62.5
MLVs
3
0.1133 ± 0.0773
250
3
0.1108 ±0.0790
1250
3
0.1453 ±0.0515
62.5
ULVs
3
0.0714 ±0.0188
250
3
0.0732 ± 0.0051
1250
3
0.08173 ±0.0277
Samples contained 20 mg/mL ULV or MLV soy PC in phosphate buffer, 83.3 pM DTPA, and 21.2
mM ABAP. Samples were bubbled with gas of varying O2 concentrations. Data were obtained
using the oxygen electrode method.
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Table A.5. Tabulated data fo r in h ib itio n by a-T in SDS m icelles, MLVs, and
ULVs, shown in Figure 3.3.
[a-T] (nM)
n
% Inhibition ± a
Membrane Model
(# observations)
SDS M icelles3

MLVs

ULVsc

1.5
2.0
2.5
3.0
5.0
7.5
10.0
12.5
15.0
20.0
25.0
30.0
5
10
15
25
50
60
75
90
100
125
150
200
15
25
35
50
60
70
75
80
90
100
110
125
150
200

1
2
3
2
5
3
4
2
4
5
3
1
1
1
1
2
2
1
2
1
2
1
2
2
1
1
1
1
1
3
2
3
4
3
1
2
1
1

26.8
63.2 ±2.97
73.2 ±10.4
83.3 ±13.7
67.3 ±15.3
83.3 ±10.1
89.5 ±4.4
85.7 ±13.2
87.2 ±1.5
63.9 ±15.9
60.6 ±9.0
69.3
18.4
79.7
86.0
107.6 ±1.8
99.7 ± 35.6
87.1
82.3 ±12.3
80.6
74.7 ±1.7
47.6
30.8 ±15.5
23.4 ±4.7
5.1
13.8
47.9
96.5
112.4
97.6 ±26.8
114.5 ±14.8
98.5 ±41.5
102.8 ±31.9
100.9 ±43.8
109.4
93.4 ±19.3
89.9
55.9

Samples contained increasing concentrations of a-T in either a. 15 mM SDS micelles in buffer,
46.7 mM linoleic acid, 80 jiM DTPA, and 20 mM ABAP, and b, c. 20 mg/mL MLV or ULV soy
PC in buffer, 21.2 mM ABAP, and 88.3 nM DTPA. Data were obtained using the oxygen
electrode method.
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Table A.6. Tabulation of data measuring the inhibition of a-T with and
without free fatty acids, shown in Figure 3.4.____________________
n
[a-T]
% Inhibition ± c r
Membrane Model
(#
observations)
(pM)
1
0
0
ULVs, -FFA

ULVs, +FFA

25
75
100
175
0
5
10
50
100
150
200

1
1
1
1
1
2
1
1
2
2
1

22.5
56.9
74.9
98.4
0
65.9 ±30.9
81.9
109.8
88.0 ±14.1
97.3 ±13.5
111.1

System contained 5 mg/mL ULV soy PC in phosphate buffer, 100 nM DTPA, 5 mM ABAP, and
100 fiM oleic add in some samples. Data were obtained using the oxygen electrode method.

Table A.7. Tabulation of data obtained for measuring the entrapped
volume of ULVs, shown in Figure 3.5.
[Cr]/[T)
n
Membrane Model
% Intensity ± a
(# observations)
0
1
100
Tris buffer
5
10
20
25
30
40
50
60
70
80
90
100
110
120
130

1
1
1
2
1
1
3
2
2
3
1
3
1
1
1

69.0
48.5
19.5
16.7
12.3 ±4.2
6.1
4.3 ±2.0
3.8 ±2.7
2.6 ±1.1
1.7 ±0.6
1.4
1.4
0.9
0.9
0
(table con’d)
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ULVs

ULVs, a-T

ULVs, stearic
acid

ULVs, a-T,
stearic acid,

0
10
30
40
50
60
70
80
90
100
110
120
130
0
40
60
80
90
100
110
120
130
0

2
2
i
1
3
2
4
4
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1

100
26.8 ± 2 .7
17.7
13.7
9.1 ± 1.8
10.2 ± 2 .6
8.2 ±2.5
7.7 ±2.4
10.0 ± 3 .4
8.8 ± 0.5
8.5 ±0.5
7.9 ± 0.2
7.1 ±0.9
100
16.2
11.3
11.5
2110.7
10.6
9.6
9.5
8.8
100

60
80
90
100
110
120
130

3
2
3
4
4
4
4

7.6 ±0.5
8.0 ±1.7
7.3 ±0.3
7.0 ±1.3
6.8 ±1.2
6.4 ± 1 .4
5.9 ±1.4

0
80
90
100
110
120
130

1
1
1
1
1
1
1

100
9.5
9.5
8.8
8.7
8.4
7.8

Systems contained 60 mg/mL soy PC in Tris buffer containing 0.5 mM TEMPOL, and with and
without 300 |iM a-T, and 1200 pM stearic acid. Ionic strength was maintained throughout.
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Table A.8. Tabulated data fo r m easuring the in hibitio n by MAC-acetamide,
U74389, and U74006, shown in Figure 4.2.____________________________
A n iio xid a n i
[Antioxidant]
n
% in hibitio n ± o
(# observations)
OiM)
1
19.1
MAC-acetamide
25
1
30.0
50
1
100
44.0
1
125
46.1
150
1
37.7
175
1
48.4
200
1
56.9
25
1
26.9
U74389
50
15.0+4.0
1
70
49.0
80
1
35.9
1
100
42.9
125
66.0 ±15.0
150
39.9 ±20.2
175
1
57.0
200
1
73.4
10
1
U74006
18.3
50
1
17.4
75
1
43.1
100
51.6 ±14.7
150
1
56.7
175
1
44.9
200
1
54.5
Samples contained 21.2 mM ABAP and 83.3 |iM DTPA in 20 mg/mL ULV soy PC. Data were
obtained using the oxygen electrode.
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